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Chapter 1 - Heart Failure in Primary Care
Introduction
“Congestive heart failure (CHF), a clinical syndrome due to heart disease, 
characterised by breathlessness and abnormal sodium and water retention, 
often resulting in oedema. The congestion may occur in the lungs or peripheral 
circulation or both, depending on whether the heart failure is right-sided or 
generalised.”
(Saunders 2000)
Congestive heart failure is the end stage of functional and structural diseases of 
the heart. The most common cause of heart failure in the United Kingdom is 
coronary heart disease which accounts for approximately 36% of cases.(Cowie 
et al. 1999) Other primary aetiologies include hypertension, valvular heart 
disease, arrhythmias in particular atrial fibrillation, and heart muscle 
abnormalities such as cardiomyopathies.
The clinical condition heart failure has been recognised for many centuries. It 
was described by many of the ancient civilisations and early treatments included 
the use of foxglove, blood-letting and leeches. The work of William Harvey on 
the circulation in the early 1600’s increased understanding of the 
pathophysiology of heart failure. Important landmarks in the natural history of
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this condition include the introduction of thiazide diuretics in 1958 and the 
CONSENSUS trial which showed improved survival in heart failure patients with 
ACE inhibitors in 1987. (Davis, Hobbs & Lip 2000) More recent advances in 
treatment such as implantable cardiac defibrillators and surgical interventions 
have improved survival but despite an improved understanding of heart failure 
and its treatments, the disease remains incurable. While survival has increased 
dramatically in recent years (Levy et al. 2002) progressive decline in health and 
ultimately death are inevitable.
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Pathophysiology of heart failure
The heart and peripheral blood vessels adapt in heart failure in order to maintain 
cardiac output and peripheral tissue perfusion. This compensatory process 
allows good levels of function when heart failure is mild, however as the disease 
progresses these mechanisms may become inadequate and clinical symptoms 
develop.
There are many different clinical syndromes of heart failure. There are usually 
classified according to chronicity or the site of the heart affected.
Acute heart failure describes the sudden onset of cardiac failure which usually 
occurs in the setting of myocardial infarction when there is loss of ventricular 
muscle function. If the underlying cause is treated the heart function may return 
but often these patients go on to develop chronic heart failure.
The term chronic heart failure refers to any clinical heart failure syndrome which 
is not acute. Chronic heart failure may be further categorised into left heart 
failure, right heart failure, systolic heart failure and diastolic heart failure. Other 
less common descriptive terms include high output, low output, dilated, non- 
dilated, ischaemic cardiomyopathy and hypertensive cardiomyopathy.
Left heart failure is a failure of adequate output by the left ventricle usually as a 
result of ischemic heart disease, hypertension, acquired mitral or aortic valvular
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regurgitation, aortic stenosis, most forms of cardiomyopathy, and congenital 
heart disorders. The symptoms of left heart failure are predominantly dyspnoea, 
orthopnoea, paroxysmal nocturnal dyspnoea and fatigue.
In contrast right heart failure is a failure of normal functioning of the right 
ventricle which usually occurs in association with left heart failure, pulmonary or 
tricuspid valve disease or lung disorders such as chronic lung disease or 
pulmonary hypertension. As with left heart failure, fatigue is a feature of right 
heart failure but in addition, patients with this condition also complain of 
breathlessness, anorexia and nausea due to fluid accumulation and resulting 
distention of the systemic veins.
In systolic heart failure or systolic ventricular dysfunction, the ventricle contracts 
poorly and empties inadequately leading to a decreased ejection fraction (Figure 
1). Systolic heart failure is most commonly due to myocardial infarction, 
myocarditis, and dilated cardiomyopathy. Systolic heart failure may affect 
primarily the left ventricle or the right ventricle.
Diastolic heart failure or diastolic ventricular dysfunction is caused by impaired 
ventricular relaxation leading to impairment of diastolic ventricular filling and 
therefore reduced cardiac output. This condition is particularly common in the 
elderly as resistance to filling increases with age, probably due to myocyte loss 
and increased collagen deposition in the myocardium. Diastolic heart failure also
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predominates in hypertrophic cardiomyopathy, hypertension, aortic stenosis, 
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Figure 1
Image from www.med.uc.edu. downloaded 13th July 2009
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The distinctions of left, right, systolic and diastolic heart failure indicate the site 
of pathology leading to heart failure and can be useful for investigation and 
management. However as the heart is an integrated pump it is rare for any part 
to fail in isolation. Therefore in clinical practice it is more common to see patients 
with elements of both left and right, and diastolic and systolic heart failure. The 
term congestive heart failure is therefore used in clinical settings to describe the 
clinical syndrome which may present with a mixture of symptoms and signs.
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Epidemiology of heart failure in the United Kingdom
Historically there have been difficulties in obtaining accurate data on the 
epidemiology of heart failure due to a lack of agreement on a definition for heart 
failure. Although heart failure is a clinical diagnosis many studies have used left 
ventricular ejection fractions obtained from echocardiograms to define levels of 
dysfunction. As there is no agreed cut-off value for an ejection fraction which 
indicates a diagnosis of heart failure each study has used different values, 
leading to conflicting data.(Davis, Hobbs & Lip 2000)
The Framingham heart study, based in the United States of America, is a unique 
longitudinal study which commenced in 1948 and spans two generations. The 
Framingham heart study assessed 5209 patients every 2 years from 1948 to try 
and determine the incidence and prevalence of heart failure. Incidence rates 
from the Framingham data show an annual rate of 0.14% for women and 0.23% 
for men when adjusted for age. The Framingham study also noted that the 
prevalence and incidence of heart failure increased dramatically with age and 
that the incidence is higher in men than in women.(Ho et al. 1993b)
The Framingham study data have been followed by more recent studies 
including the Hillingdon study which was based in general practice. In the 
Hillingdon heart study new cases of heart failure, presenting in the period April 
1995 to December 1996, were identified from a population of 151,000 served by 
82 general practices in Hillingdon, London UK. They reported incidence rates
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from 0.2 per 1000 in those aged 35-44 years increasing to 11.6 per 1000 in 
those over 85 years and they identified a median age of presentation of 76 
years. Figure 2 shows how they found the incidence to increase with age and 
amongst men more than women. The most common underlying aetiological 
conditions were coronary heart disease, hypertension, valvular disease and 
atrial fibrillation.(Cowie et al. 1999)
25- 35- 45- 55- 65- 75- 85+ 
34 44 54 64 74 84
Age (yrs)
Figure 2
Incidence of heart failure per 1000 in adults at different age groups adapted from 
the Hillingdon Heart Study (Cowie et al. 1999)
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Information from these studies and the increasing heart failure hospital 
admission rates in the United Kingdom (British Heart Foundation 2004) suggest 
that the incidence of heart failure is increasing. The incidence of heart failure is 
directly associated with increasing age. (Cowie et al. 1999) As life expectancy in 
the United Kingdom is increasing the incidence of heart failure will increase due 
to the rising older population. Ongoing advances in medical and surgical 
treatments have also contributed to the increase in heart failure incidence.
These advances lead to higher survival rates from cardiac conditions such as 
myocardial infarction. Patients who survive cardiac events will often have 
impairment in heart function and develop chronic heart failure. Another factor 
which may contribute to increasing numbers of patients with heart failure is the 
improvement in mortality rates due to standardisation of care based on evidence 
based guidelines in primary and secondary care, for example the Department of 
Health National Service Framework for coronary heart disease (Department of 
Health 2000) and the NICE guidance for management of chronic heart failure 
(National Institute for Health and Clinical Excellence 2003). There is evidence 
that the incidence of heart failure patients in general practice is increasing.(Ellis, 
Gnani & Majeed 2001) With the rising elderly population the number of patients 
in the community with heart failure is set to continue to increase with significant 
implications for the provision of community based care.
Heart failure accounts for over 5% of medical admissions to hospital in the 
United Kingdom. The total direct medical cost of CHF in the UK is currently
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estimated in excess of £625 million with hospital inpatient care accounting for 
approximately 60% of this total.(British Heart Foundation 2007) The costs 
accrued in the primary sector are also significant with an estimated 7.6 million 
general practice consultations for heart failure in the United Kingdom in 2000. 
The approximate cost of this condition to general practice is approximately £104 
million per year. (British Heart Foundation 2007) Data from the Quality and 
Outcomes Framework would indicate that in 2007 there were approximately 
15,000 patients with heart failure in Northern Ireland. (Department of Health, 
Social Services and Public Safety, Northern Ireland 2007) However the true 
number of patients living with the condition is likely to be much higher due to 
underreporting.
A diagnosis of heart failure can be suspected from clinical symptoms and signs 
but should always be confirmed using an objective measure of ventricular 
structure and function. The National Service Framework for coronary heart 
disease supports the use of an objective measure for accurate diagnosis when 
heart failure is suspected in primary care. (Department of Health 2000) Prior to 
this publication a diagnosis was often made by general practitioners on the basis 
of clinical features alone. With the introduction of the new General Medical 
Services contract in 2004 came the Quality and Outcomes framework (QOF). 
The QOF was intended to improve the quality of general practice care and 
reward GPs for implementing good evidence based practice in their surgeries. 
GP’s were rewarded financially for meeting targets in various clinical and
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organisational domains. The clinical domains included targets in chronic disease 
areas such as heart failure.
A total of 1000 points are available to GPs for meeting the requirements set out 
by QOF. Currently, 20 of these points are allocated for heart failure targets. To 
obtain these points practices are expected to meet the criteria listed below:
• Produce a register of heart failure patients
• The information should include the percentage of patients with a 
diagnosis of heart failure which has been confirmed by an 
echocardiogram or by specialist assessment and this should be between 
40 and 90%. Those who do not have a confirmed diagnosis should have 
the reason for exemption reported. Referral for Echocardiogram or 
specialist to be made within 12 months of diagnosis or within 3 months 
before diagnosis entered for diagnoses made after 1st April 2006
• Record the percentage of patients with a current diagnosis of heart failure 
due to LVSD (left ventricular systolic dysfunction) who are currently 
treated with an ACE inhibitor or Angiotensin Receptor Blocker, who can 
tolerate therapy and for whom there is no contra-indication also needs to 
be listed and should be between 40 and 80%.
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The introduction of QOF has not only improved the treatment of patients though 
standardisation of care and evidence based practice, but also made GP records 
of patients with chronic disease more accurate and searchable. Previously in 
research of heart failure in general practice the selection and therefore 
recruitment of patients has been difficult. Patients were identified on the basis of 
disease codes for heart failure and also on the basis of drug therapies used to 
treat heart failure. As a result patients who did not have a confirmed diagnosis of 
heart failure or were on drug treatments for other conditions may have been 
identified from searches. However, with a need for GPs to review patients on 
their heart failure registers on a yearly basis, to meet QOF targets, more 
accurate identification of patients is now possible.
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Symptoms of heart failure
In left sided heart failure, the most common symptoms are dyspnoea, and 
fatigue. Breathlessness can present in various ways, depending on the severity 
of heart failure. In milder cases of heart failure patients may be completely 
asymptomatic or may complain of exertional dyspnoea, which is dyspnoea 
which occurs during exertion and is relieved by rest. The degree of activity which 
induces exertional dyspnoea will vary depending on the level of left ventricular 
failure. Exertional dyspnoea may be absent in patients with very severe failure if 
they have low activity levels or are sedentary.
As the heart failure progresses, dyspnoea can occur during rest and at night 
resulting in orthopnoea and paroxysmal nocturnal dyspnoea. Orthopnoea 
describes breathlessness occurring immediately or soon after lying flat and 
relieved promptly by sitting up while paroxysmal nocturnal dyspnoea (PND) is 
breathlessness which awakens patients from sleep and is relieved only after 
sitting up.
Non-specific symptoms such as fatigue and weakness are very common in heart 
failure patients. These generally develop due to poor perfusion of the skeletal 
muscles resulting in structural and metabolic changes. Although these features 
are generally reported in more severe heart failure, intermittent fatigue and 
weakness are also common in earlier stages. Other non-specific symptoms
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include cool peripheries, dizziness, nocturia, and weight loss. Significant weight 
loss is a poor prognostic sign and is associated with high mortality.
Reduced cardiac output resulting in reduced cerebral blood flow and 
hypoxaemia may affect cerebral function. In studies assessing the symptoms 
experienced by heart failure patients many report increased confusion 
(Nordgren, Sorensen 2003) and memory impairment. There is some evidence of 
heart failure being associated with effects on cognitive function.(Taylor, Stott 
2002, Vogels et al. 2007) In an interview study 12 weeks after hospital 
admission more than half the patients interviewed reported loss of memory for 
recent events.(Lainscak, Keber 2003)
In right sided heart failure congestion affects the liver, gastrointestinal tract and 
the limbs resulting in the most common symptoms of ankle swelling and fatigue. 
Gastrointestinal symptoms are also prominent and include anorexia, nausea, 
constipation and occasionally abdominal pain. Breathlessness is a less common 
feature in right sided heart failure compared to left sided heart failure but may 
occur in the latter stages when cardiac output is severely compromised.
As clinical presentation differs depending on the degree of left sided or right 
sided failure, symptoms in heart failure patients are usually graded by a 
functional classification. The New York Heart Association (NYHA) Classification 
of Heart Failure is the most widely used functional classification used in clinical 
practice and in research to assess heart failure symptom severity.
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The NYHA developed its first classification to grade clinical severity of heart 
failure in 1928. The classification has been amended and updated many times 
since then. The latest edition was revised by the Criteria Committee of the 
American Heart Association in 1994 and is outlined in Table 1.
New York Heart Association (NYHA) Classification
Class 1 Patients with cardiac disease but without resulting 
limitation of physical activity. Ordinary physical activity 
does not cause undue fatigue, palpitation, dyspnoea 
or angina symptoms.
Class II Patients with cardiac disease resulting in slight 
limitation of physical activity. Ordinary physical activity 
results in fatigue, palpitation, dyspnoea or angina 
symptoms.
Class III Patients with cardiac disease resulting in marked 
limitation of physical activity. They are comfortable at 
rest. Less than ordinary activity causes fatigue, 
palpitation, dyspnoea or angina symptoms.
Class IV Patients with cardiac disease resulting in inability to 
carry on any physical activity without discomfort. 
Symptoms of heart failure or the angina 
may be present even at rest. If any physical activity is 
undertaken, discomfort increases.
Table 1
New York Heart Association (NYHA) Classification, adapted from (Butler 2007)
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As outlined in Table 1, the NYHA classification has four functional classes which 
grade the severity of heart failure. In clinical practice, class I and II will generally 
include patients with mild symptoms, while class III and IV indicate moderate to 
severe heart failure. The NYHA is a useful assessment tool as it provides a 
standardised description of severity that can be used to assess the impact of 
heart failure on a patient’s functional ability as well as the response to any 
treatments administered. The NYHA classification does not always reflect heart 
failure severity due to the variation in patients’ perception of symptoms and 




Investigation and Diagnosis in General Practice
The clinical diagnosis of heart failure is difficult in general practice. Patients with 
heart failure may present with non-specific symptoms and may have co-existing 
conditions which have similar symptom profiles. The accurate diagnosis of heart 
failure is becoming increasingly important with the development of medical and 
surgical interventions which can improve patient outcomes. There is evidence 
that general practitioners have high false positive rates when diagnosing heart 
failure clinically. (Sparrow et al. 2003) The UK National Service Framework 
therefore recommends all patients with suspected heart failure undergo 
echocardiography.(Department of Health 2000)
The National Institute for Clinical Excellence issued guidance on the 
investigation of heart failure in general practice in July 2003. The algorithm in 
Figure 3 illustrates the current appropriate investigation of a patient presenting 
to general practice with symptoms of heart failure. The guidelines recommend 
that a 12-lead electrocardiogram, a chest X-ray, haematological and biochemical 
investigations should be initiated in general practice for patients with suspected 
heart failure.(National Institute for Health and Clinical Excellence 2003) Although 
these investigations indicate if heart failure is a probability and exclude other 
conditions, they do not establish a diagnosis and their contribution to 
assessment of severity of heart failure is limited.
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Natriuretic peptides are a more recent development in the investigation of 
suspected heart failure patients. The presence of a raised concentration, 
particularly of the B-type natriuretic peptide, has been shown in studies in both 
primary and secondary care to provide an indication of left ventricular 
dysfunction.(Mant, Hobbs & Glasziou 2008, Maisel et al. 2002, Cowie et al. 
1997)
However natiuretic peptide levels may be elevated in other conditions such as 
hypoxaemia, renal failure, liver cirrhosis and sepsis. A study of 621 patients in 
general practice found evidence of poor overall diagnostic accuracy of BNP 
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The investigation of suspected heart failure in General Practice, adapted from 
Management of chronic heart failure in adults in primary and secondary care. 




The introduction of the echocardiogram was a key turning point in the diagnosis 
and investigation of heart failure and it remains the most commonly used 
diagnostic tool today.(Davis, Hobbs & Lip 2000)
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Management of heart failure in General Practice
Heart failure can be managed using three main treatment modalities, non- 
pharmacological, pharmacological and surgical interventions. The main aims of 
treatment are symptom control, delayed progression of disease, reduction in 
hospital admissions, extension of life and improvement in quality of life.
In primary care the mainstay of heart failure treatment involves a combination of 
non-pharmacological and pharmacological therapies. Surgical interventions only 
apply to specific patients and these are confined to secondary care.
Non-pharmacological treatments are an important adjunct to pharmacological 
treatments in heart failure. Examples of these are dietary adaptations such as 
reduction of salt, fluid and alcohol, exercise rehabilitation programmes, 
psychological interventions, and patient education, which can be used when 
appropriate.
NICE issued guidelines in the management of chronic heart failure in adults in 
primary and secondary care in 2003. The main groups of drugs used in the 
treatment of heart failure are shown in the algorithm (Figure 4) adapted from 
these guidelines. Angiotensin converting enzyme (ACE) inhibitors are the first 
line treatment and have been shown in many large randomised trials to improve 
both morbidity and mortality.(The CONSENSUS Trial Study Group 1986, The 
Study of Left Ventricular Dysfunction (SOLVD) Investigators 1991) The major
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adverse effects of ACE inhibitors include cough, hypotension, hyperkalaemia, 
renal disturbance and allergic reactions. The Angiotensin 2 receptor antagonists 
are similar to the ACE inhibitors but have the advantage of being able to be 
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Pharmacological treatment of heart failure in General Practice, adapted from 
Management of chronic heart failure in adults in primary and secondary care. 




Despite being negative inotropes, beta blockers are beneficial in heart failure 
management. The study CIBIS-I found that the introduction of bisoprolol to 
traditional heart failure therapy resulted in a reduction in hospital 
admissions.(CIBIS Investigators and Committees 1994) The follow on study 
CIBIS-II confirmed this and also showed reduced mortality rates in patients 
treated with beta blockers. (Thomas 2000) As a result it is now recommended 
that beta blockers should be added following titration of an ACE inhibitor. In 
clinical practice this tends to be performed under specialist supervision in 
secondary care.
Diuretics are useful for control of symptoms such as breathlessness due to lung 
congestion and peripheral oedema, however there is no evidence of improved 
survival with these medications. Digoxin is also used as an adjunct, particularly 
in patients with co-existing atrial fibrillation but evidence to date does not show 
any reduced mortality with the use of digoxin in heart failure.
As with other chronic diseases, it is important when treating patients with heart 
failure that a holistic approach to treatment is adopted. An improvement in 
physical symptoms may be achieved by following the guidance on 
pharmacological management but patients will often have psychological and 
social needs which also need addressed in primary care.
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Mortality and prognosis in heart failure
Follow up of patients in the Framingham study identified very high mortality rates 
in heart failure patients when compared to other chronic diseases.(Ho et al. 
1993a) The median survival following diagnosis of heart failure from this study 
was shown to be only 1.66 years in men and 3.17 years in women.(Ho et al. 
1993a)
Heart failure, in its later stages, also carries a worse prognosis than most 
cancers. A population based study comparing heart failure and cancer survival 
highlighted the high mortality in heart failure. Heart failure patients had a poorer 
5 year survival rate than all the cancers studied except for lung cancer and this 
lead to the description of heart failure as “more malignant than cancer”. (Stewart 
et al. 2001) In a Norweigan study investigating symptoms experienced by heart 
failure patients in the last six months of life, breathlessness, ankle swelling, 
fatigue and limitation in physical activity were the most commonly reported 
symptoms. (Nordgren, Sorensen 2003) This study was preceded by the RSCD - 
Regional Study of Care for the Dying, 1996 which interviewed carers of patients 
who had died from heart disease. (McCarthy, Lay & Addington-Hall 1996) Pain 
was the most common symptom reported in this study, followed by dyspnoea. 
Both these studies highlight that the symptoms experienced by heart failure 
patients are very similar to those described by cancer patients. However the 
studies were both retrospective and the findings are limited due to potential 
recall and reporting bias. The RSCD relied on carers recalling symptoms 10
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months after death while the Norweigan study relied on reporting of symptoms in 
patients’ records. This study recognised the need for further qualitative research 
to determine the views of these patients in order to improve care in end-stage 
heart failure. (Nordgren, Sorensen 2003)
Despite having similar prognostic outcomes and patients reporting similar 
symptoms, the end-stages of heart failure and cancer may vary. The disease 
trajectory in heart failure is less predictable than in cancers and can be highly 
variable. (Lunney et al. 2003, Gott et al. 2007). Patients may experience a 
chronic decline but acute exacerbations with subsequent recovery are a feature 
of heart failure, as is sudden death with no preceding decline in 
function.(Uretsky, Sheahan 1997) This leads to difficulties in estimating 
prognosis and instigating appropriate care, particularly in general practice.
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Palliative care in heart failure
The symptoms experienced by patients with end-stage heart failure are 
distressing, poorly controlled and similar to those of patients dying of 
cancer.(McCarthy, Lay & Addington-Hall 1996) The difficulty in predicting 
prognosis is one of the barriers to referring heart failure patients for palliative 
care.
By definition palliative care is the active, holistic care of a patient with advanced, 
progressive illness. (Nordgren, Sorensen 2003) Palliative care aims to improve 
the quality of life for patients and their families facing life-threatening illness by 
identifying their physical, psychological and spiritual problems and treating these 
accordingly. (World Health Organisation 2007) Traditionally the use of palliative 
and supportive care has been associated with patients who have a cancer 
diagnosis. However, the need for this type of care provision to be extended to 
chronic illnesses, such as heart failure, is now recognised. (Ward 2002)
The Gold Standards Framework (GSF) is an evidence (Thomas 2000) based 
guideline which aims to optimise the care for patients nearing the end of life in 
the community. This guideline recognises the need to identify patients with non­
cancer conditions who require palliative care input. The GSF has developed 
criteria to enable identification of heart failure patients with palliative care needs:
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• Patient in NYHA class III or IV
• Patient thought to be in the last year of life
• Patient who has been admitted to hospital frequently with heart failure 
symptoms
• Patient with difficult physical or psychological symptoms despite optimal 
medical therapy
In general practice these criteria can be used to identify heart failure patients 
and, using the palliative care model, address their physical, psychological and 
social needs with the ultimate aim of improving quality of life.
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Chapter 2 - Quality of life in heart failure patients: a literature
review
What is quality of life?
In treating heart failure health professionals aim not only to relieve symptoms 
and prolong life, but also to improve quality of life. Traditionally the outcome 
measures used in clinical trials in heart failure have been confined to exercise 
capacity, recurrent hospitalisation, left ventricular ejection fraction and death. 
However, quality of life is becoming increasingly recognised as a potential end­
point for intervention trials in heart failure.
Quality of Life (QOL) is defined by the World Health Organisation as a “state of 
complete physical, mental and social well-being and not merely the absence of 
disease”. (Celia 1994) In contrast to this, health-related quality of life (HRQL) 
represents a patient’s satisfaction with the domains of life as affected by health 
or the difference between an individual’s current function and their expected 
health status. (Masoudi et al. 2004)
“ The terms quality of life and more specifically health related quality of life refer 
to the physical, psychological, and social domains of health, seen as distinct 
areas that are influenced by a person’s experiences, beliefs, expectations, and 
perceptions.” (Testa, Simonson 1996) As a result there are an infinite number of
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states of quality of life. The effect of disease on quality of life is highly individual 
dependent. For example two patients of the same age, social circumstances and 
similar symptoms of disease may perceive their quality of life very differently due 
to the influence of their experiences, perceptions, beliefs and particularly - their 
expectations.
Patients with heart failure may have significant functional limitations.(Stewart et 
al. 1989) Functional status reflects the ability to carry out tasks or everyday 
functions without significant limitation. This may include physical, social, and 
mental functions.
There is no agreed definition of what constitutes the domains which contribute to 
quality of life. It is believed that many factors may exert an influence on an 
individual’s quality of life and many conceptual frameworks exist. Models 
commonly include domains such as physical, psychological and spiritual health, 
each of which may have many sub domains. The World Health Organisation has 
produced generic quality of life instruments, developed simultaneously in 15 field 
centres around the world, known as the WHOQOL. In the development of these 




Patients with a range of diseases•
• Well people
• Health professionals
The background research was performed in a variety of cultures and the 
instrument was rigorously tested to assess its validity and reliability in each of 
the field centres. Six broad domains of quality of life, and twenty-four facets 
were identified in the rigorous development of these quality of life 
questionnaires. The table below (Table 2) has been adapted to illustrate these 
domains and facets of quality of life.
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Domain Facets incorporated within 
domains
........................................................................
(1) Physical health • Energy and fatigue
• Pain and discomfort
• Sleep and rest









• Activities of daily living
• Dependence on medicinal 
substances and medical aids
• Work capacity
(4) Social Relations • Personal relationships
• Social support
• Sexual activity
(5) Environment • Financial resources
• Freedom, physical safety and 
security
• Flealth and social care: accessibility 
and quality
• Home environment
• Opportunities for acquiring new 
information and skills
• Participation in and opportunities for 
recreation/leisure
• Physical environment 
(pollution/noise/traffic/climate)
• Transport
(6) Spirituality/ Religion/ 
Personal Beliefs





Quality of life domains and facets. Adapted from the World Health Organization 
(1993). WHOQoL Study Protocol.
Quality of life in heart failure: the evidence
The detrimental effects of heart failure on quality of life have been recognised as 
early as 1963 when physical and mental stress were identified in end-stage 
heart failure patients in a London hospital.(Hinton 1963) More recently the 
Medical Outcomes study (Stewart et al. 1989) assessed quality of life in 9385 
patients with various chronic diseases. Patients with heart failure showed 
significant impairment in the physical and mental health domains and those with 
advanced heart failure had similar scores to patients with major depression 
measured on mental health scales. (Stewart et al. 1989) Heart failure patients 
have poorer quality of life than those with other chronic diseases such as 
hypertension, diabetes and chronic lung disease.(Stewart et al. 1989, Hobbs et 
al. 2002)
A literature review on the effect of quality of life in heart failure was performed 
using the keywords ‘heart failure’, ‘quality of life’, and ‘health related quality of 
life’. The database Medline was used for the searches and searches were 
combined to identify literature which contained both the keywords ‘heart failure 
and quality of life’ or ‘heart failure and health related quality of life’. Articles were 
examined for suitability and references in the individual articles were also
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explored. The original search was performed in August 2007 and repeated at 
intervals until May 2009 to identify any additional publications.
The generic framework of domains and facets which contribute to quality of life, 
such as the WHO outline, (Table 2) can also be applied to heart failure patients. 
In addition disease specific conceptual models have been developed to explain 
the interaction between disease and quality of life. The flowchart in Figure 5 was 
developed by Thomas Rector, one of the authors of the Minnesota Living with 
Heart Failure quality of life questionnaire. The flowchart illustrates how 
symptoms of heart failure may directly impact quality of life and the concept that 
the effect of these symptoms in terms of functional limitation and psychological 
distress can also impair quality of life. This conceptual model however lacks the 
detail of individual quality of life domains shown in Table 2 and also does not 














Conceptual model of the relationships between heart failure pathophysiology, 




Symptoms and quality of life
In further work Rector et al tested the conceptual model (Rector, Anand & Cohn 
2006) and found that symptoms of heart failure alone explained 41% of the 
variation in the effects of heart failure on quality of life. The authors used data 
from the Valsartan Heart Failure trial (Rector, Anand & Cohn 2006, Rector, Kubo 
& Cohn 1987) to assess the contribution of symptoms such as dyspnoea on rest 
and exertion, paroxysmal nocturnal dyspnoea, orthopnoea, fatigue and New 
York Heart association class on quality of life scores as measured by the 
Minnesota Living with Heart Failure questionnaire (MLwHF). Fatigue explained 
38% of variation in MLwHF scores with dyspnoea explaining 28% of the 
variation. The other symptom based variables exerted a less significant effect on 
variation in quality of life scores however patient demographics also contributed 
to the variation of quality of life a small degree.
Heart failure patients report a wide range of symptoms. A sample of 60 hospital 
outpatient heart failure patients had a mean of 9 symptoms, measured using the 
Memorial Symptoms assessment Scale-Short form. In this cohort of patients as 
symptoms increased, disease specific quality of life decreased and symptoms 
accounted for 32% of the variance in quality of life. This study also explored the 
relationship between depression and quality of life and found that the presence 
of depression was associated with higher reporting of symptoms and poorer 
quality of life. (Bekelman et al. 2007)
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The importance of symptomatic heart failure on quality of life as opposed to the 
diagnosis alone was highlighted by the ECHOES study group.(Hobbs et al.
2002) They used the SF-36 on patients referred from the community for 
assessment of heart failure. The quality of life scores of those who were 
diagnosed as having heart failure (n= 426) were compared with the outcomes 
for the patients who did not have heart failure (n=3850). A significant impairment 
was noted in physical and mental health of the heart failure patients when 
compared to the normal population. However those with asymptomatic heart 
failure had similar scores to the population sample, highlighting the impact of the 
symptoms rather than the disease itself on quality of life. (Hobbs et al. 2002)
The symptoms experienced by heart failure patients may differ according to 
stage of disease. In a retrospective review of the medical records of patients 
with end stage heart failure, patients reported an average of 6.7 symptoms. 
Breathlessness was the most common symptom, pain the second most frequent 
and fatigue the third most common symptom. (Nordgren, Sorensen 2003) Pain 
is a symptom which is expected in cancer patients nearing the end of life but 
would not be a typical symptom of heart failure. It was however found to be a 
problem in the last six months of life in 78% of the patients studied in the 
Regional study of care for the dying (Addington-Hall, McCarthy 1995) including 
patients with heart failure.
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Disease severity and quality of life
The stage or severity of heart failure and its impact on quality of life have been 
studied at length in secondary care. Most studies use a functional classification 
such as the NYHA classification or an objective measure of failure severity such 
as left ventricular ejection fraction. Irrespective of the grading system used, 
increasing heart failure severity has been found to be associated with 
significantly poorer quality of life. (Hobbs et al. 2002, Azevedo et al. 2008, 
Juenger et al. 2002, Gott et al. 2006) It could be argued however, that by using 
a classification like the NYHA class to define heart failure severity and asking 
patients which group they fall into is an indirect reflection on their perception of 




Psychological health and quality of life
In addition to multiple physical symptoms heart failure patients may suffer 
impairment of quality of life through psychological distress. The medical 
outcomes study reported high levels of depression in patients with heart failure. 
(Stewart et al. 1989) Other studies have found that the levels of psychological 
distress in heart failure are comparable to that of cancer. (Addington-Hall, 
McCarthy 1995) and the impact of depression on quality of life is known to be 
associated with higher mortality in heart failure.(Murberg et al. 1999)
Psychological distress in patients with heart failure in primary care may be 
under-diagnosed. Patients with heart failure recruited from general practice in 
Germany completed the Hospital Anxiety and Depression scale, a disease 
specific quality of life instrument and a ‘coping with illness’ questionnaire at 
baseline and then 9 months later. Higher levels of psychological dysfunction 
(depression and/or anxiety measured by the HADS) were observed in patients 
with higher NYHA class and in those with background emotional problems. 
Positive influences on psychological health included the presence of social 
support and living with a partner. (Scherer et al. 2007) Psychological distress 
has a significant association with quality of life. Rector’s conceptual model 
recognises this association and studies have shown that psychological ill-health 
leads to poorer quality of life in patients with heart failure. (Bekelman et al. 2007, 
Azevedo et al. 2008, Scherer et al. 2007)
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Patient characteristics and quality of life
The effect of demographic factors on quality of life may vary depending on the 
disease being studied. In heart failure the influence of patient demographic 
factors on quality of life in secondary care patients is well reported although 
conflicting evidence exists. Azevedo et al reported poorer quality of life in older 
patients using the SF-36. (Azevedo et al. 2008) However, a multicentre 
prospective cohort study assessing how age and functional capacity impact 
upon quality of life showed that older age was independently correlated with 
better HRQL. At baseline in this study older patients had better quality of life 
scores, measured by the Kansas City Cardiomyopathy Questionnaire, than 
younger patients despite having poorer levels of functional capacity. (Masoudi et 
al. 2004) In a study looking at symptoms and quality of life, demographic factors 
such as race, gender and co-morbidity explained less than 1% in the variation in 
quality of life but age explained an additional 4.5% in variation. (Rector, Anand & 
Cohn 2006)
Women with heart failure appear to have lower quality of life scores than men in 
hospital based studies (Azevedo et al. 2008) and in heart failure patients 
recruited from primary care (Gott et al. 2007). No studies identified from the 
review reported any significant differences in men and women in terms of age or 
disease severity, therefore it is not known why gender in heart failure patients 
should influence quality of life.
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Evidence also suggests that marital status has an effect on both heart failure 
prognosis (Rohrbaugh, Shoham & Coyne 2006) and quality of life (Scherer et al. 
2007). Relationship quality has been shown to be a predictor of 8-year survival, 
especially in female heart failure patients (Rohrbaugh, Shoham & Coyne 2006).
Heart failure patients will often have multiple co-morbid conditions. Bekelman et 
al recognised the potential influence of co-morbidity on symptoms in heart failure 
patients.
“Many of the symptoms reported are not generally thought of as being caused 
by heart failure... (they) may be associated with co morbid illnesses...” 
(Bekelman et al. 2007)
The effect of co-morbid conditions on quality of life in heart failure patients 
varied in different studies. Levels of co-morbidity are generally thought to be 
associated with impairment in health related quality of life.(Gott et al. 2006) 
Rector et al found in their study that the variation in quality of life scores 
explained by co-morbidity was less than 1%, (Rector, Anand & Cohn 2006) 
however the co-morbid conditions studied were limited to ischaemic heart 
disease, hypertension, diabetes and atrial fibrillation.
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Quality of life of heart failure patients in General Practice
Most of the quality of life data for patients with heart failure has been obtained 
from trials in secondary care. Older patients are under-represented in these 
trials. Women and those with co-morbidity are also under-studied. (Heiat, Gross 
& Krumholz 2002, Krumholz 1998, Masoudi et al. 2003)
There are a few studies reporting the impact of heart failure on quality of life 
within community settings. This limits the relevance of existing quality of life data 
to patients being managed in the community.
Two studies have explored quality of life in patients recruited from primary care. 
The ECHOES study (Hobbs et al. 2002) recruited patients from primary care 
and through screening with echocardiography identified heart failure patients 
and used the SF-36 to measure their quality of life. Patients over the age of 45 
were randomly selected from 16 general practices in the West Midlands and 
NYHA grading was performed by a consultant. This study showed the heart 
failure patients had significant impairment in quality of life compared to those 
without heart failure and that NYHA class was associated with SF-36 score. 
However the study used a generic quality of life measure rather than a disease 
specific measure and demographic characteristics of patients were not 
considered.(Hobbs et al. 2002)
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A prospective postal questionnaire survey performed in general practice in four 
areas of the United Kingdom recruited a total of 542 patients over the age of 60 
years with heart failure. (Gott et al. 2006)Factors found to be associated with a 
decreased quality of life in heart failure patients included:
• Female gender
• New York Heart Association (NYHA) functional class 3 or 4
• Evidence of depression
• Lower socioeconomic status
• Experiencing two or more co-morbidities. (Gott et al. 2006)
The data collection for this study was performed prior to the introduction of the 
Quality and Outcomes framework for General Practice and therefore recruitment 
of patients was more difficult. The researchers used disease codes and 
medications used in heart failure to identify patients. GPs then excluded patients 
if they felt they did not have heart failure. The evidence used in their decision 
was not specified and may have been inconsistent as patients may have a 
clinical diagnosis of heart failure, but not necessarily a diagnosis confirmed by 
echocardiogram. This study used two quality of life instruments, a generic tool 
(SF-36) and a disease specific instrument (the Kansas City Cardiomyopathy 
Questionnaire). Using these two measures added strength to their findings 
however the age group was limited to those over 60 years so the results cannot
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be used to make assumptions regarding the quality of life of younger patients in 
the community.
Quality of life has been shown to be a reliable predictor of mortality and 
hospitalisations in heart failure patients.(The Study of Left Ventricular 
Dysfunction (SOLVD) Investigators 1996) In addition knowledge of quality of life 
in heart failure patients is important for physicians in order to improve patient 
care. Further research is required in general practice as the evidence available 
has limitations and may not be applicable to certain age groups and other 
populations, such as Northern Ireland.
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Qualitative research in heart failure
“Qualitative research is multi-method in focus, involving an interpretive, 
naturalistic approach to its subject matter. This means that qualitative 
researchers study things in their natural settings, attempting to make sense of, 
or interpret, phenomena in terms of the meanings people bring to them.” 
(Wilems et al. 2006)
Qualitative research is an ever increasing method of data gathering in health 
care research. It aims to explore patients’ experiences, ideas, processes and or 
beliefs in the particular area of interest. Qualitative methods may be used in 
isolation or combined with other forms of research methodology.
Qualitative data may be gathered in many ways. In health care research data 
are usually obtained through interviews and or focus groups. Other types of 
qualitative data include open comments in questionnaires, case study notes, 
and minutes of meetings, personal documents and even visual material such as 
photographs.
Qualitative research can answer questions which are beyond the realms of 
quantitative research. It can describe, explain and attempt to understand a 
particular research question and can inform us as health care providers how 
various diseases impact on the individual rather than the general population.
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Despite this, qualitative research is not without rigour. Quantitative research 
achieves scientific rigour through validity, reliability, objectivity and 
generalisability. The scientific rigour in quantitative research is achieved through 
the processes of credibility, fittingness, auditability and confirmability. (Wilems et 
al. 2006) Credibility describes the extent to what findings and interpretations are 
credible with the sources from which they are drawn while fittingness refers to 
how the study context fits with the practice context. The ability to follow the data 
analysis process or decision trial is auditability and if another researcher is able 
to arrive at the same conclusions the data is confirmable.
The impact of chronic disease on patients’ everyday lives is a good example of 
how qualitative research is useful in healthcare. Studies gathering data on the 
drug treatments used in heart failure and how they affect quantitative outcomes 
e g. symptoms scores or six minute walk tests, are abundant. These are very 
useful in evidence based practice and can improve patient outcomes but they 
tell little of the health related issues which are important to the patients 




Living with heart failure
A study explored the perceptions of patients with end stage heart failure 
regarding the ‘work’ of every-day living. The authors interviewed 31 patients with 
NYHA stage III or IV heart failure at baseline and conducted follow up interviews 
at 3-5 month intervals. Their objective was to explore how these patients lived 
and what work was involved in this, regardless of any work related to paid 
employment. Using a prospective longitudinal design, semi-structured interviews 
were performed until data saturation was reached. The following domains were 
used to categorise potential areas of patient work in heart failure:
• Managing the illness
• Everyday work to keep life going
• Biographical work
• Arrangement work
Patients reported work organising medications and fluid intake as main tasks in 
management of their illness. They felt having to be organised and strict in timing 
of activities was restrictive. They also described how fatigue dominated daily life 
to the extent that every-day activities such as eating, bathing and going to the 
toilet had become so energy consuming that they became serious work. Loss of 
social activities and being unable to attend events was the main limitation in 
biographical work while household adaptations and the effort to obtain these
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required arrangement work. (Wilems et al. 2006) This information is vital in 
understanding how patients perceive work due to their condition. This type of 
data and level of detail could not be achieved through quantitative means.
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Patient’s perception of quality of life - qualitative view
Heo et al (Heo et al. 2009) used a qualitative approach to explore how patients 
with heart failure defined and perceived quality of life. Through semi-structured 
open-ended interviews with 20 heart failure patients the most common definition 
of quality of life from the patient’s perspective was “the ability to perform physical 
and social activities”. Content analysis of the interviews revealed that patients 
identified three key components of quality of life:
1. Performing physical and social activities
2. Maintaining happiness
3. Engaging in fulfilling relationships
Certain influences were noted to have negative or positive effects on quality of 
life including physical factors such as symptoms, physical status, psychological 
factors such as mood, perspective and social factors such as social support and 
ability to perform social activities. Spiritual, behavioural and economic influences 
were also identified as having potential positive or negative effects. This study is 
important as few investigators have examined quality of life from the heart failure 
patient perspective. However a convenience sample of patients who lived in a 
Midwestern city in the United States was used in this study and the average age 
of the study participants was 58 years with 70% of them men. This data 
therefore may not reflect the opinions of other heart failure patients as the 
sample was predominantly male and this cohort of patients is much younger
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than the general heart failure patient population.(Heo et al. 2009) Bosworth et al 
(Bosworth et al. 2004) also used qualitative methods to investigate how patients 
with heart failure perceived quality of life and in particular, its components. They 
used focus groups and identified five quality of life domains: symptoms, role 
loss, affective response, coping, and social support. Participants in this study 
reported worries for their family and the uncertainty of prognosis as areas of 
concern. (Bosworth et al. 2004)
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Unmet needs in heart failure
As previously discussed, patients with heart failure have a similar prognosis to 
many cancer patients and share common symptoms towards the end of life. The 
disease trajectory of heart failure is less certain and this is a potential barrier for 
the introduction of palliative care to these patients. The principles of palliative 
care allow a holistic care approach with tailoring to the individual’s needs. 
Without palliative care input, this may be absent and as a result patients may 
have unmet needs. In chronic illness, like heart failure, deteriorating health 
status, decreased independence and social isolation are problems that patients 
may report.(Fitzsimons et al. 2007) Some needs which have been identified 
through qualitative interviews include:
• Physical needs e.g. deteriorating health status and limited resources
• Emotional needs e.g. worries and concerns for the future
• Social needs e.g. lack of social support
The authors of this study recognised that the needs of patients with advanced 
chronic illness are complex and a more-timely implementation of palliative care 
is necessary in order to meet these needs.(Fitzsimons et al. 2007) Further 
research in this area, particularly concentrating on heart failure patients in 
isolation, would be necessary in order to improve their care.
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Quality of life in heart failure: conclusion
Heart failure is a complex clinical syndrome which has high levels of morbidity, 
mortality and, like other chronic diseases, can detrimentally affect quality of life. 
There is conflicting evidence of the variables which affect the quality of life in 
heart failure patients. Most of the evidence to date has been gathered from 
clinical trials in secondary care using selected, hospital based patients. This 
does not represent the typical heart failure population seen by a general 
practitioner. As increasing numbers of heart failure patients are now being 
managed in the community and information on their quality of life is limited, it is 
imperative that further research in this area is performed. The impact of heart 
failure on quality of life cannot be observed directly, to measure this it is 




Chapter 3 - Measuring quality of life in heart failure
Measuring quality of life using questionnaires
Quality of life can be described as both subjective and multidimensional. (Celia 
1994) It is subjective as it can only be measured from the patient’s perspective 
and multidimensional as in order to assess it information must be gathered from 
various aspects of the patient’s life. (Celia 1994)
Quality of life questionnaires aim to gather information from the patient’s 
perspective, measuring various domains, and translate this into a quality of life 
scale score. This information can be used to assess the impact of a disease on 
an individual, as well as determining the success of a particular intervention in 
research or clinical practice.
There are many different types of quality of life questionnaires. The output and 
its relevance will be influenced by the degree of objectivity of the dimensions 
measured, the emphasis on various domains, and the format of the 
questionnaire. The degree to which various components or domains are 
included will depend on the patient population on which the questionnaire is to 
be used. However despite variation to truly measure health related quality of life, 
an instrument must evaluate physical, emotional and social well-being.
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Questionnaires should also show evidence of:
• Reliability The outcome is consistent with repeated
measurements
• Validity The tool measures what it claims to measure
• Responsiveness It is able to detect true changes or differences
Quality of life questionnaires used in health care research generally fall into one 
of two groups: generic or disease specific instruments.
Page
54
Generic quality of life instruments
Generic quality of life questionnaire are designed to be broadly applicable 
across diseases and health conditions, they are not specific to any particular 
disease or population of patients. They should summarise health across various 
aspects of quality of life and be applicable to a wide range of healthcare 
interventions. The strength of generic quality of life tools is their use in 
conducting general research or making comparisons on quality of life in differing 
subsets of patients. They are less useful in gaining detailed quality of life data in 
patients with a particular condition.
There are a wide variety of generic quality of life instruments available. The 
Medical Outcomes Study 36-Item Short Form (SF-36) Health Survey, the 
Nottingham Health Profile (NHP), the Sickness Impact Profile (SIP), the 
Dartmouth Primary care Cooperative Information Project (COOP) Charts, the 
Quality of Well-Being (QWB) Scale, the Health Utilities Index (HUI), and the 
EuroQol Instrument (EQ-5D) are the most commonly used in the English 
language literature.(Coons et al. 2000) Of the instruments reviewed for this 




The Short-Form 36 and Short-Form 12
The Medical Outcomes study 36-Item Short Form Health Survey (SF-36) is a 
generic questionnaire developed which demonstrates a high degree of internal 
consistency and test -retest reliability. (Stewart et al. 1989) It is well validated in 
a variety of patient groups and is comparable to the Nottingham Health Profile 
(NHP). (Brazier, Harper & Jones 1992) The SF-36 discriminated between heart 
failure patients and those with other chronic diseases in the Medical Outcomes 
study. It does however have some limitations. For example, it does not cover the 
area of sleep disturbance. (Berry, McMurray 1999). It is also lengthy and 
potentially difficult to complete, and as a result it has poor response rates in the 
elderly. (Jenkinson, Layte & Jenkinson 1997)
A shortened version of the SF-36 is available in the form of the Medical 
Outcomes Study 12-Item Short Form (SF-12). The SF-12 is a 12 item- 
instrument consisting of two major summary scales, the physical component 
scale (PCS) and the mental component scale (MCS). The SF-12 has 
comparable validity to the SF-36. (Ni et al. 2000) The two measures have been 
compared in different patient groups, including a study of patients with heart 
failure. (Jenkinson, Layte & Jenkinson 1997) The SF-12 has also been 
compared to the disease specific tool, the Minnesota Living with Heart Failure 
questionnaire (MLwHF). (Ni et al. 2000) In this prospective cohort study of heart 
failure patients attending a university-based clinic the SF-12 was more sensitive 
to changes in physical health but less sensitive to changes in mental health. The
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MLwHF was more sensitive to changes overall. As a result the SF-12 in isolation 
is not recommended for detecting changes in quality of life in heart failure 
patients. If a generic quality of life measure is appropriate it should be combined 




Disease specific quality of life instruments
A disease specific quality of life questionnaire is designed to be used in a 
specific condition or patient population. The domains included will be selected 
for their relevance and to cover the typical symptoms of the condition. Disease 
specific quality of life questionnaires will be piloted and validated in their target 
population, therefore they usually cannot be applied to other populations as the 
validity in these populations will be unknown. The strength of disease specific 
quality of life tools is their use in conducting research on quality of life or 
evaluating the effect of a therapeutic intervention in patients with a certain 
condition. Their main limitation is the narrow range of application.
Disease specific questionnaires used in heart failure have been designed to 
assess symptoms and other domains of quality of life that are typically affected 
by the condition. The most commonly used disease specific questionnaires 
developed for use in heart failure patients are the Minnesota Living with Heart 
Failure Questionnaire (MLwHF), the Chronic Heart failure Questionnaire 
(CHFQ), the Quality of Life Questionnaire for Severe Heart Failure (QLQ-SHF), 




The Minnesota Living with Heart Failure questionnaire (MLwHF)
The Minnesota Living with Heart Failure questionnaire (MLwHF) was developed 
in 1984 by Rector et al. (Rector, Kubo & Cohn 1987) It consists of 21 questions 
assessing physical symptoms and signs, physical functioning, social functioning, 
emotional functioning, sexual functioning and ability to work. Questions are 
answered on a Likert type scale ranging from 0 which represents ‘no’ to 5 which 
corresponds to ‘very much’. The total score for the questionnaire is calculated by 
adding the individual question scores with a possible range of 0 to 105. A 
Physical dimension scale can be obtained by summing the individual scores 
from questions 2, 3, 4, 5, 6, 7, 12, and 13. The possible range for the physical 
dimension score is 0 to 40. An emotional dimension scale can be obtained by 
summing the individual scores from questions 17, 18, 19, 20 and 21. The range 
for this dimension is 0 to 25.
The MLwHF is well validated in trials assessing baseline quality of life 
characteristics (Gorkin et al. 1993), pharmacological (Rector, Cohn 1992) and 
non-pharmacological interventions. (Smith etal. 1997)
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Comparisons of quality of life measures used in heart failure
A literature review was performed to find literature comparing quality of life 
measures used in heart failure populations through the Medline database. The 
keywords used were ‘quality of life’, ‘questionnaires’, ‘compare’, and ‘heart 
failure’. The search results were examined for appropriate individual studies, 
review articles, systematic reviews and meta-analyses. A total of five documents 
were identified as relevant, two review articles comparing the generic and 
disease specific measures used in heart failure research, one systematic review 
with meta-analysis of disease specific measures only, and two studies 
comparing the MLwHF and the Short Form questionnaires.
In the first review article (Berry, McMurray 1999) the authors reviewed the 
design and validation literature for use of the following generic and disease 
specific questionnaires in patients with heart failure, the Sickness Impact Profile, 
the Short Form 36, the Nottingham Health Profile, the Quality of Wellbeing 
Scale, the Minnesota Living with Heart Failure questionnaire, the Quality of Life 
in Severe Heart Failure questionnaire and the Chronic Heart Failure 
questionnaire. They found inconsistent performance and sensitivity in all the 
questionnaires studied. The SF-36 and the Sickness Impact Profile exhibited the 
best qualities of the generic instruments in heart failure patients while the 
MLwHF was the disease specific measure which had the optimal performance. 
The authors recognised the limitations in quality of life questionnaires in general 
and recommended that generic and disease specific questionnaires be used in
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combination to cover a wider range of domains in heart failure patients. (Berry, 
McMurray 1999)
The second review article was concerned with the ability of questionnaires to 
determine aspects of quality of life which are important to heart failure patients - 
to “take account of the patient perspective”. (Dunderdale et al. 2005) The SF-36 
was one of the generic instruments reviewed in addition to the Nottingham 
Health Profile (NHP) and the Sickness Impact Profile (SIP). The extensive use 
and validity of the SF-36 in various patient populations was noted as was its 
sensitivity to change and suitability for heart failure populations. All of the 
generic measures reviewed were recommended for use in conjunction with a 
disease specific measure in heart failure research. The authors commented on 
the lack of evidence to show that the most commonly used disease specific 
measures are patient centred. Although the measures reviewed, including the 
MLwHF, were all well validated, the authors did not make any direct 
comparisons or conclusions regarding the most appropriate tool for use. 
(Dunderdale et al. 2005)
A systematic review with meta-analyses did however directly compare disease 
specific questionnaires. They identified 421 full text peer reviewed articles of 
which 94 had data relating to the five most commonly used disease specific 
tools: the MLwHF, the CHFQ, the QLQ-SHF, the KCCQ and the LVD-36. 
Cronbach’s alpha was high for all the measures on scales indicating physical 
domains. All questionnaires had moderate to strong association with the validity
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criteria used: NYHA class, the six-minute walk test and the SF-36. The MLwHF 
was found to be the strongest disease specific measure when estimates from 
eight meta-analyses were pooled and this evidence would support its use as a 
first line disease specific measure in heart failure patients. (Garin et al. 2009)
Disease specific measures are more useful in measuring quality of life than 
generic tools in heart failure populations. (Ni et al. 2000, Bennett et al. 2002) 
Generic measures should not be used alone but may be combined with a 




Emotional disorders and psychological distress are common in heart failure 
patients and need to be considered when assessing quality of life. The generic 
and disease specific measures have emotional or mental components but the 
impact of psychological distress in heart failure patients may require the use of a 
specific tool. The Hospital Anxiety and Depression Scale (HADS) is one such 
example.
The (HADS) is a 14-point survey which was developed to screen for anxiety and 
depression among patients in non-psychiatric hospital clinics. (Zigmond, Snaith 
1983) It consists of seven anxiety subscale questions and seven depression 
items. It has demonstrated reliability and validity in both primary and secondary 
care.(Bjelland et al. 2002) It is an adequate screening tool in primary care and 
compares favourably with the Mini International Neuropsychiatric Interview 
(MINI) (Bunevicius et al. 2007) and the Patient Health Questionnaire (PHQ-9) 
(Cameron et al. 2008) which are also used to screen for mental disorders in 
primary care. It has been used to successfully identify psychological distress in 
heart failure patients recruited from general practice. (Scherer et al. 2007)
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Measuring quality of life in heart failure: conclusions
Quality of life is both subjective and multi-dimensional. It must be measured 
from the patient’s perspective and information on various aspects of the patient’s 
life is required for its adequate assessment. Questionnaires are a useful tool in 
measuring quality of life and may be generic or disease specific in nature. 
Generic instruments, such as the SF-12, aim to summarise health across 
various aspects of quality of life but when used to assess quality of life for 
patients with heart failure should be combined with another instrument due to 
their lack of sensitivity to change. The SF-12 and the MLwHF are well validated 
tools and have been tested for use heart failure patients. As quality of life in 
these patients is often affected by psychological distress, a tool such as the 
HADS may be used to complete a global quality of life assessment.
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Chapter 4 - A study exploring quality of life and unmet needs of
patients with heart failure in a General Practice population
Introduction
As highlighted in the literature review heart failure is a condition which results in 
considerable morbidity and mortality. (Davis, Hobbs & Lip 2000, Davis, Albert & 
Young 2005) The detrimental effect of heart failure on quality of life is well 
documented but there is a poor level of understanding of the impact of this 
disease on patients’ daily lives.
Quality of life data in patients with heart failure have traditionally been obtained 
through clinical trials in secondary care. There is evidence that the patients who 
are enrolled in these trials are not representative of the heart failure patient 
population (Krumholz 1998, Masoudi et al. 2003) and do not reflect the patients 
seen in general practice.
The high incidence of cardiovascular disease and the increasing ageing 
population make heart failure likely to cause a considerable workload for general 
practice in the future. Following the introduction of the Quality and Outcomes 
Framework in general practice, heart failure registers have facilitated more
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accurate identification of patients with this condition. This has facilitated the 
recruitment of patients with a confirmed diagnosis of heart failure for this study.
The principle aim of this piece of work is to gather information about quality of 
life and unmet needs of patients with heart failure in the Northern Ireland 
community. This information is not currently available and is necessary for 




The aim of this study is to explore quality of life and unmet needs in heart failure 
patients in the Northern Ireland general practice population.
Study Objectives
• To examine differences in self reported quality of life between people in 
NYHA classes I and II and classes III and IV
• To explore if quality of life in heart failure patients is associated with 
disease, demographic and social factors
• To identify the unmet needs of patients’ with severe heart failure (NYHA 
classes III and IV) in order to suggest improvements for their future care
Study Hypothesis
It is hypothesised that quality of life, as measured by the disease specific 
questionnaire, will be significantly reduced in patients with a higher NYHA class. 
Increasing age, lower social class, higher levels of co-morbidity and living alone 
would also be expected to be associated with a significant reduction in quality of 





The study had two distinct stages with a mixed method design. The design was 
chosen as it was felt to be the most appropriate to meet the study objectives 
(see page 67). The first stage, a cross sectional postal questionnaire survey, 
involved gathering quality of life data from a wide range of heart failure patients 
throughout Northern Ireland. The second stage aimed to assess individual 
patient’s perceived unmet needs using semi-structured interviews. A qualitative 
approach is particularly appropriate when assessing unmet needs as a patient’s 
perception of need is highly variable and is difficult to assess using a 
standardised tool.
In the first stage quality of life data was obtained using three well validated 
questionnaires, the Minnesota Living with Heart Failure questionnaire (MLwHF), 
the Short Form-12 (SF-12), and the Hospital Anxiety and Depression scale 
(HADS). These were posted to heart failure patients identified from general 
practice heart failure registers. Quality of life scores were then analysed for 
significant differences depending on disease factors (NYHA class, co-morbid 




Purposive sampling was used to identify participants for stage 2 of the study 
from stage 1 respondents. A range of patients and potentially information rich 
cases were identified to be invited to participate in the semi-structure interviews.
Methods for stage 1
A sample of general practices in Northern Ireland was invited to participate in 
the study. The practices were randomly selected to be representative of 
Northern Ireland general practices in terms of list size and geographical location. 
Randomisation was used in the selection process to reduce selection bias.
The Department of Health Social Services and Public Safety list of QOF 
practices from 2007 to 2008 (Department of Health, Social Servies and Public 
Safety 2009) was used to stratify practices in terms of list size and board area 
and 10 practices were randomly select by the study statistician using random 
number tables. Initially stratification in terms of socioeconomic status was also 
considered in selection of practices, however given the small sample size (n=10) 
which was being drawn from the sample frame, it was not possible to stratify for 
a further variable. The number of practices chosen was based on the study 




The sample size calculation was based on the primary research question and 
the primary outcome measure selected to address this question.
Primary research question
Is there a difference in self reported quality of life between patients in NYHA 
classes I and II and patients in NYHA classes III and IV?
Primary outcome measure
The primary outcome measure was the quality of life score as calculated by the 
Minnesota Living with Heart failure questionnaire. It was expected that a 
significant difference in quality of life scores would be demonstrated between 
patients in NYHA classes I and II and those in NYHA classes III and IV, using 
this primary outcome instrument. The sample size calculation was based on the 
likely size of the difference (in terms of mean and standard deviation scores) 




To compare the mean quality of life scores for each group (NYHA Ml and NYHA 
lll-IV) the equation for comparative research studies was used. (Eng 2003)
The equation used can be expressed as follows:
N = 4ct2 (Zen, + Zpwr)2
D2
Where:
N = sample size
a = the standard deviation of each group (this was assumed to be equal for 
both groups, and the value used was obtained from a study which looked at 
discriminant properties of quality of life tools in heart failure.(Bennett et al. 2002) 
Zen, = 1.96 (Z value which corresponds to the 95% confidence levels)
Zpwr = 1 -282 (Z value which corresponds with a desired power of 0.90)
D = The minimum expected difference between the two means
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Therefore using the standard values and those obtained from previous research:





This equation does not take clustering effects into account. Therefore based on 
the assumption that the number of patients obtained from each GP practice 
would be approximately equal and using the sample size of 76, we estimated 
that approximately 8 patients would be obtained from each cluster.
When measuring subjective assessments of health-related quality of life we 
expect a range of factors to influence outcomes, however the GP practice is 
unlikely to play a part in this. As a result of this the intra-cluster correlation was 
expected to be low in this sample and a cluster correlation of 0.01 was chosen 
by the study statistician. This resulted in a design effect of 1.07, and an 
increased sample size of 82.
Therefore sample size allowing for clustering = 82
Page
72
Recruitment of adequate sample size
An estimated response rate of thirty percent was used to predict the numbers
needed to recruit.
Nrecruit/100 X 30 = 82
N recruit X 3 = 820
N recruit = 274
The average practice heart failure prevalence in Northern Ireland is 
approximately 0.82%.(Department of Health, Social Services and Public Safety, 
Northern Ireland 2007) Using this average prevalence a sample it was estimated 
that to recruit 274 patients with heart failure approximately 10 practices would 
need to be recruited to the study.
Practice and Participant recruitment
The practices selected were sent the study information by post and asked to 
return the consent form if they wished to participate. The practices who did not 
respond were sent a reminder letter after 2 weeks. Practices which declined 
participation or those who did not respond to either invitation were replaced with 
a practice matched for list size and board area. A total of nine practices were
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recruited within the time frame allocated for recruitment (December 2008 to April 
2009).
When recruited, practices were asked to identify patients from their heart failure 
registers who met the study’s inclusion criteria as below;
• Diagnosis of heart failure identified from the practice heart failure register.
• Age greater than 18 years
• Able to complete a questionnaire
• No cognitive dysfunction
• Able to consent to participation in the study
• English speaking
Patients under the age of 18 were excluded as the focus of the study was adult 
patients with heart failure. Due to restrictions on translated versions of the study 
questionnaires, those who did not speak English were also excluded.
Following identification of potential participants the practice then forwarded the 
study information to these patients. The information sent to the potential 
participants included: (See Appendices);




• A demographic questionnaire
• The Short-form 12 (SF-12)
• The Hospital Anxiety and Depression scale (HADS)
• The Minnesota Living with Heart Failure Questionnaire (MLwHF)
• A study consent form
• A stamped addressed envelope for return of the survey to the researcher
From the pilot work it was estimated that recruiting 10 practices would allow 
identification of adequate numbers of patients for this study. The sample size 
calculation was based on the likely effect size of the difference in quality of life 
scores between patients in NYHA classes I and II and those in classes III and IV 
using the MLwHF (See pages 71-73). A sample size of 82 participants was 
required to detect a significant difference at 90% power and 95% confidence. 
The response rate was estimated at 30% therefore approximately 274 patients 
would need to be sent the study information in order to get an adequate sample 
based on the pilot work.
In the first stage of the study quality of life data was collected using the three 
well validated quality of life questionnaires: the Minnesota Living with Heart 
Failure questionnaire (MLwHF), the Short Form 12 (SF-12) and the Hospital 
Anxiety and Depression scale (HADS). These questionnaires were chosen to 
cover a wide range of domains that were thought to contribute to quality of life. 
Both disease specific and generic quality of life instruments were included to
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measure if variables affected disease specific quality of life and generic quality 
off life differently. As the study participants were being asked to complete three 
questionnaires the shorter SF-12 was chosen instead of the SF-36.
Questionnaires were returned to the researchers at the Department of General 
Practice, Queen’s University Belfast. The participating practices were asked to 
provide anonymous data for all patients sent the study information so the 
characteristics of the responders and non-respondents could be analsysed for 
any significant differences. The anonymsed patient characteristics provided by 
the practices included age, gender, and postcode.
The postcodes of patients were used to calculate a multiple deprivation measure 
score.
“The Northern Ireland Multiple Deprivation Measure (Nl MDM) is the official 
measure of spatial deprivation in Northern Ireland.” (Northern Ireland Statistics 
and Research Agency 2008)
For the purposes of calculation of the Nl MDM the geographical area of Northern 
Ireland is divided into 890 super output areas (SOA). Each SOA covers a 
population of approximately 1800 people and information from seven domains 
are used to determine the MDM score and rank of this pre-defined area. The 
domains included in the MDM equation are: Income deprivation, Employment 
deprivation, Health Deprivation and Disability, Education Skills and Training
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deprivation, Proximity to Services deprivation, Living Environment deprivation, 
and Crime and Disorder. Each of these domains carries a specific weight and 
the Nl MDM score is the combined sum of the weighted, exponentially 
transformed rank of the domain score. A deprived area will therefore have a low 
MDM score and a low MDM rank.
The postcode of each patient sent the study information was used to determine 
their corresponding SOA. The Nl MDM score of each SOA was translated into a 
MDM score using tables provided by the Northern Ireland Statistics and 
Research Agency.
Data analysis
The data obtained from the postal questionnaire survey was entered into SPSS 
version 16 and this software package was used for analysis. The MLwHF and 
HADS questionnaires were scored manually and the SF-12 questionnaires were 
scored using the Health Outcomes Scoring package provided by the licensing 
authority. Analysis of data was performed in the Department of General Practice 
at Queen's University, Belfast with support from the study statistician.
The primary outcome measure used was the quality of life score as calculated 
from the MLwHF questionnaire. The mean MLwHF scores from patients in New 
York Heart Association (NYHA) groups I and II were compared with the scores 
of patients in NYHA class III and IV with an independent t-test. This process was
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repeated for the secondary outcome measures. The mean scores obtained from 
the SF-12 PCS and the SF-12 MCS and the HADS in NYHA class I and II
patients were compared with those obtained from patients in NYHA class III and 
IV.
The effect of demographic characteristics such as age, gender, co-morbidity, 
social class and marital status on quality of life scores was analysed for each 
questionnaire using multiple regression.
The variables such as co-morbidity and marital status were entered into SPSS 
as binary response variables. One of the assumptions of regression is that the 
independent variables within the model are not related. If variables within the 
model are related collinearity will exist. This can be problematic in small studies. 
When co-morbidity and marital status were entered into the regression model in 
the study the tolerance values for these variables approached 0.2 indicating 
significant collinearity. To rectify this one of the co-morbid categories and one of 
the marital status categories were removed from the model and the others were 
compared to the category which was omitted. Following this the tolerance 
values, which indicate the degree of collinearity, were much higher than 0.2. 
Variables were then removed from the model using backward elimination to 
leave only the significant variables. However due to the need to omit one of the 
co-morbid and marital status categories, it was not possible to remove individual 
categories. The significance of these collective group of categories was 
determined by examining the effect of removing all or none of the categories on
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the R2 value. The R2 value indicates the degree of variation in the dependent 
variable which can be attributed to the independent variables. Therefore if the 
marital status categories were removed and the R2 value decreased it indicated 
that marital status had a confounding effect as it contributes to the variation in 
the dependent variable i.e. the quality of life score. All marital status categories 
would be replaced in the model even if some of the individual categories were 
not significant.
Bivariate analysis was used to determine the significance of individual co-morbid 
conditions such as lung disease, arthritis, and angina when co-morbid was 
found to be confounding.
The characteristics of the respondent s and non-respondents were compared 
using Chi-square for gender, the Mann Whitney U test for MDM score and the 
independent t-test for age.
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Methods for stage 2
The second stage of the study aimed to identify patients' unmet needs through 
semi-structured interviews. Purposive sampling was used and variables such as 
age, gender, geographical location, heart failure severity, and quality of life 
scores were considered in selection of participants. The aim was to identify a 
wide range of patients and potentially information rich cases. These patients 
were expected to have a wide range of unmet needs and therefore more likely to 
highlight areas for improvement of heart failure care. The general practitioners 
were asked to identify patients with a history of violent behaviour as these 
patients were not selected for interview in order to minimise any risk to the 
researcher. Patients were contacted by telephone to inform them of selection for 
interview and to confirm consent for participation. Initially a purposive sample of 
approximately 10 participants was selected for participation in the second stage 
of the study. However due to time limitations and a lack of patients with severe 
heart failure consenting to interview, a total of 3 patients were interviewed.
A semi-structured interview format was used and interviews were conducted in 
the home of each patient. This format allowed some loose structure to focus the 
discussion while using open-ended questions encouraged patient directed 
responses. The interview questions were constructed considering the purpose of 
the research, results from the existing literature, and topics of interest to the 
researcher. The interviews were generally patient directed. However questions 
were constructed to ensure that the interview covered important areas. An
_______ Page _______ _______
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inductive approach was used throughout the interviews. All interviews were 
conducted by the lead researcher (MM) and were recorded using a digital 
recorder. The length of each interview was directed by the patient. The set 
questions included in the semi-structured interviews are included in appendix 
12.
Interviews were conducted during May 2009. The audio files were transcribed by 
researcher and the transcripts were analysed using a framework for thematic 
analysis. Due to the limitation in the number of interviews data saturation was 
not achieved in the qualitative interviews and as are result these results may 
only be used to inform the qualitative data as in isolation they lack rigour.
Ethical considerations of the study
Confidentiality of participant data
Patients were given a unique study code at recruitment. This code appeared on 
each questionnaire so that responders were able to be identified. Only 
anonymous data was removed from the practice. The names, personal details 
and their corresponding codes were stored separately from the study data in a 
password protected file on a university computer.
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Interviews in medical research pose a risk of disclosure of important information. 
This was discussed by the research team prior to data collection. If a patient 
made a clinical disclosure which may have required action it was agreed that the 
researcher would encourage the patient to go to their own GP or ask the 
patient's permission to do so on their behalf. As a medical practitioner, under the 
duties of a doctor and also as a researcher practising ethically it would not be 
appropriate to break the confidentiality of the interview. In the event of a 
disclosure which suggested that the patient was at risk, for example suicidal 
intent, or that not taking action would put others at risk of significant harm, the 
case would be discussed within the research team and in the event of necessity 
to break confidentiality, the patient would be informed prior to proceeding.
Non-maleficence
This study offered no direct benefit to the participants. The sensitive and 
personal nature of quality of life issues and unmet needs were recognised by the 
research team.
The Short Form-12 includes questions about limitations in lifestyle which may 
challenge patients to consider restrictions to their activities of daily living. Some 
participants may have found these limitations in their lives upsetting. The 
Minnesota Living with Heart Failure questionnaire includes a question on 




The term 'heart trouble' was used in the study information provided to patients 
as the researchers felt some patients may not have been familiar with the term 
heart failure and may have found it distressing.
During the interview process participants may have had difficulty discussing their 
unmet needs however as the interviews were patient directed it was felt that it 
was unlikely that patients would initiate discussion which would make them 
uneasy.
Autonomy
The patient information sheet for the study states that no person was under 
obligation to participate and that their medical care will be unaffected by a 
decision not to participate. Non-respondents were not contacted by the research 




An ethical proposal for this study was accepted by the Northern Ireland 
Committee of the National Research Ethics Service. The ethics reference 
number for the study was 08/NIR02/93.
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Chapter 5 - Study Results
Practice characteristics
Nine practices from all health boards in Northern Ireland participated in the 
study. The four health boards in Northern Ireland in the years 2007/2008 were 
the Northern, Eastern, Southern and Western Health Boards. The practices 
included in the study are listed below with their corresponding board area and 
practice list size in the year ending 2007/2008. The average list size of the study 
practices was 4,821 compared to the Northern Ireland average list size of 5,164 
for the same time period. Three of the practices selected were in the Eastern 
Board area, with two practices selected from each of the other board areas. The 
Eastern board covers the city of Belfast which is the area of highest population 
density in Northern Ireland. To gain a representative sample of practices more 
practices were invited from the Eastern Board area. The average practice list 
size for Northern Ireland in 2008 was 5,164.
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From the 43,390 patients registered in the nine practices selected, 297 (0.68%) 
meet the study criteria and were invited to participate. Of the 297 patients invited 
to participate 90 replied giving an overall study response rate of 30.3%.
The study population is described in Table 4. The mean age of participants was 
73 years and the majority of participants were male (56.7%). The most common 
NYHA classes were II and III, most patients were married or lived with their 
partner and over 77% of participants had two or more co-morbid conditions. The 
most commonly reported co-morbid conditions were arthritis (51%), 
hearing/visual impairment (39%), angina (34%), lung disease (32%), diabetes 










NYHA Class n (%)
Class 1 13 (14.4)
Class II 33 (36.7)
Class III 24 (26.7)
Class IV 20 (22.2)
MDM rank
Lowest MDM rank 11
Highest MDM rank 883
Mean MDM rank 459
Marital status n (%)
Single 9 (10)




No co-morbidity 7 (7.8)
1 condition 13 (14.4)
2 conditions 21 (23.3)
3 conditions 22 (24.4)
4 or more conditions 27 (30)
Table 4 Study population characteristics (N=90)
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Number of participants % of participants with




Blood disorder 15 16.7
Asthma 8 8.9
Lung disease 29 32.2
Diabetes 23 25.6
HearingA/isual impairment 35 38.9
Cancer 6 6.7
Stroke/ Brain condition 7 7.8









There was no significant difference between the gender of the respondents and 
the non respondents (Chi square = 1.2, p = 0.274) despite slightly more females 
being invited and more males responding (see Figure 6). The mean age of the 
respondents was 73 years while the non-respondents had a mean age of 73.3 
years. No significant difference was found between the groups (t = 0.219, p = 
0.827). The respondents and non respondent also did not differ in terms of MDM 










Bar chart showing frequency of male and female respondents and non­
respondents
The Minnesota Living with Heart Failure Questionnaire (MLwHF)
A total of 87 (29.2%) valid MLwHF questionnaires were returned, 3 of the study 
participants did not complete the questionnaire. Some of the participants did not 
complete the question regarding the effect of heart failure on their ability to work 
as they were retired (See MLwHF, Appendix 10). A zero score was allocated in 
these cases.
The histogram below (Figure 7) shows that the MLwHF scores followed a near 
normal distribution. The total MLwHF scores ranged from 0 to 90. Higher 
numerical scores on the MLwHF correspond with poorer quality of life. The high 
frequency of lower MLwHF scores illustrated in Figure 7 could be due to 
response bias. Patients with less severe disease and better quality of life may 
have been more likely to respond leading to the positive skew in the results. 
However as the sample size is greater than 30 the normality assumptions for the 
statistical methods used to analyse these results can be relaxed.
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Figure 7 Histogram showing the distribution of total MLwHF scores 
Disease severity
Patients in NYHA class I and II (n=45) had a mean MLwHF score of 32 with a 
standard deviation of 3.3. Patients in NYHA class III and IV (n=42) had a mean 
MLwHF score of 60 and a standard deviation of 3.3 also. There was a highly 
significant difference in mean total MLwHF scores between these two groups
(p<0.001).
To check for the confounding effect of disease, demographic and social factors 
on the total MLwHF score a regression analysis was performed. Disease, 
demographic and social factors were responsible for 55% of the variation in
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MLwHF total scores. The variables found to contribute to the model included 
NYHA class, age, co-morbidity and marital status. Although NYHA class was the 
only variable which had a significant p value (<0.001) in the regression model, 
having no co-morbid conditions (p=0.07) and being single (p=0.06) approached 
significance. Removing the other variables resulted in a decrease in the R 
square value indicating that although the p value for these variables were not 
significant, the variables contributed to the variation in MLwHF total scores.
Marital Status
Patients who were single had lower MLwHF scores than those who were 
married while those who were widowed or separated had higher scores than 















single married or partner widowed dkorced/sep
Marital Status
Figure 8 Bar chart showing relationship between marital status and the mean 
total MLwHF score
Co-morbidity
Co-morbidity is a confounding factor in quality of life as measured by the 
MLwHF, when other independent variables are held constant. Figure 9 
illustrates the trend in mean total MLwHF scores at varying levels of co­
morbidity. Those who have 2 or less co-morbid conditions have lower scores 





Bar chart showing the trend in mean total MLwHF score at various levels of co­
morbidity
As co-morbidity was identified as a factor which contributed to total MLwHF 
score, individual co-morbid conditions were entered into a bivariate analysis to 
look for significant associations. A statistically significant correlation was found 
between MLwHF total score and having arthritis (p=0.02), blood disorders 




MLwHF Physical and Emotional Dimensions
Quality of life, as measure by the MLwHF physical and emotional health 
dimensions is also affected by NYHA class.
In the physical dimension patients in NYHA class I and II (n=45) had a mean 
score of 17 with a standard deviation of 1.7 while those in NYHA class III and IV 
had a mean score of 30 with a standard deviation of 1.3. A highly significant 
difference was found between these two groups (p<0.001).
The emotional dimension score was also affected by patients self-reported heart 
failure severity. Patients in NYHA classes I and II had a mean emotional 
dimension score of 7.1 with a standard deviation of 6.8 while those in groups 
NYHA classes III and IV had a mean score of 14 with a standard deviation of 
8.3. As with the physical dimension, a significant difference was noted between 
these two patient groups (p<0.001).
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Conclusion of MLwHF results
Disease specific quality of life in patients with heart failure in the Northern 
Ireland general practice population is affected by disease severity. The disease 
severity, as measured by the NYHA functional classification has an impact on 
both physical and emotional dimensions of quality of life. Patient factors also 
contribute to disease specific quality of life as measured by the MLwHF. In 
particular, age, level of co-morbididity, and marital status contributed to the 
variation in MLwHF scores adjusted for other factors. Patients with heart failure 
have a wide range of individual co-morbid conditions. Those which have been 
shown to be associated with disease specific quality of life include arthritis, 
blood disorders, gastrointestinal disease and psychiatric conditions.
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The Short-Form 12 results
The output from the completed SF-12 questionnaires (n=89) was entered into 
the software package producing a physical (PCS) and mental (MCS) component 
summary score. The results of the PCS and MCS were analysed separately. 
Higher numerical scores on these scales indicate better quality of life.
The physical component summary (PCS) results
Participant scores on the PCS ranged from 11.6 to 59.7 with a mean participant 
PCS of 29.7. The histogram in Figure 10 illustrates the spread of PCS scores in 
all participants. In the study sample 90% of participants were below the 
population norm used for the PCS, 6% scored at the general population norm 
and only 4% were above the general population norm (See aggregate report 
form SF-12 scoring software, Appendix 13)
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Figure 10
Histogram illustrating SF-12 PCS scores in all participants
Disease severity
Patients in NYHA class I and II had a mean PCS score of 34.1 with a standard 
deviation of 11.6 while those in NYHA class III and IV had a mean score of 24.9 
with a standard deviation of 6.4. There was a significant difference in PCS 
scores between these two groups (p<0.001).
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The independent variables were responsible for 49% of the variation in PCS 
scores. The factors which contributed in the regression model were NYHA class 
(p<0.001), gender (p=0.01) and co-morbidity. Having no co-morbid conditions 
was a significant confounder (p=0.04). Although the other categories of co­
morbidity did not have significant p values in the model, they could not be 
removed due to the significant effect of the no co-morbidity category. If all co- 
morbid categories were removed the R square value decreased indicating that 
this variable contributed to the variation in PCS scores.
Gender
Gender was a significant confounder. Females had lower scores on the PCS 

















Mean PCS scores in males and females
Co-morbidity
Patients with 1 or less co-morbid conditions had better quality of life scores on 
the PCS than those with 4 or more co-morbid conditions. The trend in PCS with 
varying levels of co-morbidity is illustrated in Figure 12. In contrast to the 
MLwHF scores, PCS scores decrease with increasing level of co-morbidity. 
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Co-morbid conditions
Figure 12
Relationship between number of co-morbid conditions and PCS score.
As with the MLwHF, arthritis was significantly associated with PCS scores, using 
bivariate analysis (p=0.005). The other co-morbid conditions which showed a 
significant correlation with the PCS score were angina (p=0.05) and hearing or 
visual impairment (p=0.03). Each of these conditions had a negative correlation 
coefficient indicating that the presence of the condition decreased quality of life 
score as measured by the SF-12 PCS.
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The Mental component summary scale (MCS)
The MCS scores from all valid SF-12 questionnaires returned (n=89) ranged 
from 16.6 to 65.7. The scores on the MCS were higher than those on the PCS 
reflected in the MCS mean of 45.9 compared to the PCS mean of 29.7. Higher 
scores on the SF-12 components indicate a better quality of life, suggesting that 
the patients in this study had better quality of mental compared to physical 
health. The histogram in Figure 13 illustrates the distribution of MCS scores in 
the study population. When the MCS scores of the study population are 
compared to population norms using the SF-12 software, 49% of the study 
participants were below the population norm, 20% scored at the population norm 
and 31% were above the population norm (See aggregate report from SF-12 
scoring software, Appendix 13)
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Figure 13
Histogram illustrating SF-12 MCS scores in all participants
Disease severity
Patients in NYHA class I and II (n=46) had a mean MCS score of 50.4 with a 
standard deviation of 10.8 while those in NYHA class III and IV (n=43) had a 
mean MCS score of 41.3 with a standard deviation of 11.1. There was a 




The independent variables which contributed to the 36% of variation in MCS 
scores were age, gender, NYHA class and marital status. Co-morbidity was not 
a significant variable in the regression model for MCS scores. NYHA class 
(p<0.001), age (p=0.04) and being divorced or separated (p=0.05) all reached 
statistical significance in the model. The other categories of marital status were 
therefore unable to be removed from the model despite not being significant 
individually. Gender approached statistical significance (p=0.08) but when this 
variable was removed from the model the R square value decreased, reducing 
the degree of variation in MCS scores explained by the independent variables. 
Therefore gender contributes to the model despite not having a significant p 
value.
Age
Age was a significant confounding variable in the MCS regression model. When 
all other independent variables are held constant a one year increase in age is 
associated with a 0.24 increase in SF-12 MCS score. This indicates that older 
patients have a slightly better quality of life, as measured by the MCS, than 
younger patients.
Marital status
The multiple regression model also indicated that marital status contributes to 
variation of MCS scores. Being divorced or separated had the most significant
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effect on scores, with these patients having significantly lower scores than those 
who were married or lived with a partner. The bar chart in Figure 14 illustrates
the relationship between marital status and SF-12 MCS score. Patients who 
were single had the highest average MCS scores of the marital groups, as was 
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Females have lower scores on the MCS in addition to the PCS. The mean MCS 
score for females was 44.5 while males had an average score of 47.1. Females 
with heart failure therefore have an overall poorer quality of life than males when 
a generic measure is used.
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Conclusion of SF-12 results
The physical and mental components of quality of life using a generic tool are 
affected by gender and disease severity (See Figure 15 and 16). Females and 
patients with more severe disease have a poorer quality of life. Physical quality 
of life is influenced by disease, demographic and social factors to a greater 
extent than mental quality of life. Co-morbidity has a detrimental effect on 
physical quality of life in patients with heart failure and conditions particularly 
associated with impaired physical quality of life include arthritis, angina and 
impairments of vision and hearing. Co-morbidity however does not affect the 
mental component of quality of life in this group of patients. Mental health is 
better in older patients with heart failure and in those who are married or live 
with a partner. Single patients also have good scores on the mental component 
scores while those who are divorced or separated have the poorest mental 



























SF-12 MCS and PCS scores in patients of varying NYHA class
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The Hospital and Anxiety Scale (HADS) results
From the completed HADS questionnaires (n=83) a total score was obtained by 
totalling the individual responses. This total score gives an overall impression of 
the level of psychological well-being in the study participants. The HADS scores 
ranged from 2 to 34. The maximum score attainable in the HADS questionnaire 
is 42. This corresponds to high levels of psychological distress. The mean 
HADS score in the study population was 14.6.
Disease severity
Patients in NYHA class I and II (n=42) had a mean HADS score of 11.1 with a 
standard deviation of 6.8 while those in NYHA class III and IV had a mean 
HADS score of 18.2 with a standard deviation of 7.5. There was a significant 
difference (p<0.001) in the level of psychological wellbeing, as measured by the 
HADS between these two groups of patients. As disease severity increased, 
psychological wellbeing in patients with heart failure decreased.
The independent variables which contributed to 48% of the variation in HADS 
scores were age, gender, NYHA class, level of co-morbidity and marital status. 
MDM score was the only variable which did not contribute to the regression 
model. The variables which were found to be significant confounders were age 
(p=0.007), NYHA class (p<0.001), and having no co-morbid conditions (p=0.05) 
Gender approached significance (0.07) but removing it from the model resulted
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in a reduction in the R square value indicating that it contributed to the variation 
in HADS scores. In the same way the categories of marital status were not 
significant in their own right but removing them from the model also resulted in a 
reduction in the R square value.
Age
Age was highly significant in the regression model. It had an inverse relationship 
with the HADS scores. With other independent variables held constant, a one 
year increase in age resulted in a reduction in the HADS score by 0.22 
indicating that in patients with increasing age HADS scores were lower. 
Therefore older patients with heart failure have better levels of psychological 
wellbeing than younger patients.
Co-morbidity
The degree of co-morbidity affects psychological wellbeing in patients with heart 
failure (see Figure 17). Patients with 2 or less co-morbid conditions have better 
psychological wellbeing than those with 4 or more conditions. Patients with no 
co-morbid conditions have significantly less impairment in psychological 
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Figure 17
HADS scores at varying levels of co-morbidity
The individual conditions which demonstrated a significant association with the 
total HADS score were blood disorders (p=0.003), gastrointestinal disease 
(p=0.008), and psychiatric illness (p=0.03). These conditions all produced a 
positive Reason’s correlation coefficient with the HADS suggesting that higher 




Single patients had the lowest HADS scores and those who were divorced or 
separated had the highest HADS scores. In the non-single patients the presence 
of an ongoing relationship protected against psychological distress. Patients 
who were married or had a partner had lower HADS scores than those who 
were divorced, separated or widowed. This is illustrated in Figure 18.
Figure 18




Female patients had higher scores on the HADS than male patients. Female 
patients with heart failure appear to have poorer levels of psychological 




Conclusion of HADS results
Psychological wellbeing in patients with heart failure is affected by disease 
factors such as disease severity and level of co-morbidity, demographic factors 
such as age and gender and social factors such as marital status. Better 
psychological health is found in older patients and men with heart failure. Single 
patients have better HADS scores than those who are married or live with a 
partner while those who are divorced or separated have the poorest scores and 
therefore the highest levels of psychological distress. The presence of co-morbid 
conditions impairs psychological wellbeing in heart failure patients. Blood 
disorders, gastrointestinal disease and psychiatric illness were identified as 




Results of stage 2 - Patient interviews
The reduced amount of data in the second stage limits its use as a qualitative 
study in isolation, however the three interviews uncovered certain themes which 
inform the quantitative data. The three participants were all in self-reported 
NYHA class 4 and were selected from the small number of stage 1 respondents 
who consented to interview. Interview transcripts were searched for recurring 
themes.
The central theme in all three interviews was reduced quality of life as a result of 
functional limitation.
“...you don’t have a quality of life, so you don’t.”
(Participant 1)
Patients viewed heart failure primarily in terms of the impact it had on their daily 
functioning.
“Simple things like showering. I showered every morning and now I can’t. When 
I do (my partner) has to dry me because I don’t have the energy to dry myself. 




The ability to do most things was affected by heart failure and several 
references were made to how current abilities to perform daily tasks compared 
to the past. The following quote is from a 54 year old gentleman who developed 
heart failure after a myocardial infarction while on a weekend away with his 
partner. He refers to his activities prior to developing heart failure and how the 
person he was before didn’t come home after that day.
“I was a maintenance electrician, very active. I was working up to six days a 
week. We went away for that weekend and I didn’t make it home. ”
(Participant 1)
The distinction between the patient’s functional abilities compared to their peers 
was also recognised.
“...even things that normally a woman of my age would just take for granted, 
you have to think about and I do everything very slowly. ”
(Participant 2)
Functional limitations in heart failure were viewed as a consequence of the 
physical and psychological impact of disease on patients’ lives. The physical 




“I just can’t do anything now...that’s basically what it is. It stops me doing 
anything at all. ”
(Participant 3)
“I get short of breath very quickly now. ...I would be tired all the time. Sometimes 
I feel as if I am tired inside, I feel weary inside. ”
(Participant 2)
“Whole life turned around. Can’t work, can barely walk at times. I get a lot of fluid 
swelling in the stomach so I have to go in and get tapped every three weeks. It 
affects the breathing too. ”
(Participant 1)
Psychological consequences included the effect of heart failure on 
concentration, memory and mood.
“....my memory is not that great now. ”
(Participant 2)
“I just can’t concentrate... I used to read but the concentration is not there. ” 
(Participant 1)
“He gets very, very depressed because he can’t get out. ”
(Partner of participant 1)
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Functional limitations led to a loss of independence and a dependence on 
family, especially partners. The importance of personal relationships in dealing 
with the effect of heart failure on life restrictions and quality of life was 
recognised.
‘‘....it takes somebody with you. I’m lucky to have that. ”
(Participant 1)
However the impact of heart failure on relationships and the subsequent feelings 
of guilt because of this were recurrent themes.
“... my husband has been held back in that.. ..sometimes I can sort of think back 
and say to myself I’m sure although we are 46 years married, it hasn’t been 
much of a married life for him. ”
(Participant 2)
Methods of improving independence were viewed as very important. All three 
patients recognised access to personal transport and mobility aids as vital in 
maintaining some independence.
“I got the (mobility) scooter and I was able to get around again. I was able to go 




“It is a mobility car and it’s a blessing....if we want to go out somewhere it will 
give me the independence to do that. ”
(Participant 2)
Loss of traditional roles and sense of self, inability to work, needing help with 
activities of daily living and house hold chores as well as the impact on leisure 
and travel were other consequences of increasing functional limitation.
“The mood gets very down (when my partners son does things in the house) 
because I will go, I should have been able to do that. ”
(Participant 1)
“That’s a photo of me two years ago before I had the heart attack. There is times 
I don’t recognise myself. ”
(Participant 1)
Hospital and community medical care was described as generally satisfactory 
but resources and at times social support were lacking. Input from heart failure 
nurses was felt to be integral in disease management and in helping patients 
cope with heart failure.
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“They (the heart failure nurses) are very good. They really are...they come round 
and If I have any questions they will explain it to you and come back again. If 
they don’t know they will find out and they will ring you back. They are brilliant. ” 
(Participant 1)
7 have her (the heart failure nurse) phone number and she would say now if you 
need me just phone. That’s a useful service. ...I really need it. I think it’s 
important. ”
(Participant 2)
Despite the satisfaction with the heart failure nurse service patients did find 
hospital care at times led to feelings of depersonalisation.
“They (the doctors) just won’t listen to you. You are not a person, so you are not. 
You are a number. The first thing they check is your wrist. You are a number 
and a piece of meat. ”
(Participant 1)
The need for greater levels of social support and financial support were 
recognised however the greatest unmet need identified was the need for better 
communication from healthcare professionals.
“I think most times you are the last to know....the consultant came round, didn’t 




“... we don’t seem, to be getting any answers.. .there is the odd doctor that right 
away you know you wouldn’t want to ask them things. ”
(Participant 2)
“To be honest with you I am not sure about the heart failure. It was all new to me 
and I didn’t know one thing from another. ”
(Participant 3)
Adequate communication regarding prognosis was often lacking and patients 
expressed their fears for the future. One participant was attending a hospice and 
recognised the benefits of this care model, despite his initial reservations to 
accept palliative care input.
“It just seemed the beginning of the end but Marie Curie have been very 
good... Everyone thinks the hospice is just for cancer, which we did too. It’s not. ” 
(Participant 1)
“I look forward and I can only see things getting worse for me. ”
(Participant 2)
“They both have lost their mum and keep wondering when I am going to go.




However despite the difficulties these patients face in dealing with the functional 
limitations, poor quality of life and daily challenges of living with heart failure, 
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Diagram illustrating the core themes identified from the interviews in the centre, 
the impact of the core themes on patients lives in the middle circle and the 
outside factors which can influence quality of life on the outermost circle.
The diagram above (Figure 19) illustrates the conclusions and themes from the 
interviews. Symptoms of heart failure and functional limitations were the core 
themes. As a result of symptoms and functional limitations, patients experienced 
feelings of loss of sense of self and roles, dependence and its impact on 
personal and family relationships, inability to work, perform activities of daily 
living and enjoy travel and leisure. Although many of these themes were found 
in all three interviews, due to the small number of interviews data saturation was 
not achieved and further research in this area is required.
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Chapter 6 - Discussion of results
Discussion of results from stage 1
The study population
The response rate for this postal questionnaire survey appears to be much lower 
than in previous studies. Typically response rates for postal questionnaire 
surveys in general practice, targeting patients with chronic disease, range from 
45% to 85%.(Gott et al. 2006) (Smith et al. 1985) However, the studies 
measuring these response rates generally use one questionnaire and the target 
patients are younger than the cohort identified in this study. The completion of 
three individual quality of life measures, in addition to the demographic 
questionnaire may have reduced the number of respondents in our study. The 
questionnaire administration method may have also contributed to the low 
response rate. Previous research has shown that postal questionnaire surveys 
in general practice have a lower response rate than direct hand delivered 
administration. (Wensing, Smits & Van Montfort 1996) Direct administration was 
not feasible given the study time frame. The response rate could also have been 
improved by the use of reminder letters. Reminder letters and repeated mail 
shots were limited by ethical and time constraints.
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Despite the low response rate, the responders in the study were representative 
of the heart failure population in general practice in Northern Ireland, the 
practices used were representative of Northern Ireland practices and the 
patients who responded were no different to the non-responders. The data from 
the primary outcome measure, the MLwHF, also indicates the study population 
was similar to other heart failure populations. The mean MLwHF total score 
across all NYHA groups in the study was 45.5, and the standard deviation was 
26.1. Previous research reports very similar descriptive statistics in larger 
numbers of heart failure patients (mean MLwHF = 45.3, SD = 27.2). (Bennett et 
al. 2002) (Wensing, Smits & Van Montfort 1996)
The Questionnaires
Quality of life in patients with heart failure can be measured using disease 
specific and generic quality of life instruments. Individual instruments may have 
emphasis on certain quality of life domains and therefore measure different 
constructs. The study data shows how the quality of life instrument used will 
affect the outcome in certain patient populations, but also how patient factors 
may affect quality of life irrespective of the instrument used. A table summarising 
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Table showing the independent variables which contributed to the variation in 
scores in the quality of life instruments used.
The relationship between marital status and quality of life demonstrates the 
importance of selecting an appropriate quality of life instrument. Marital status 
was a contributor to quality of life scores using the MLwHF, the HADS and the 
MCS scale from the SF-12. It did not contribute to quality of life scores in the SF- 
12 PCS. The SF-12 PCS measures the physical components of quality of life but 
it does not measure any emotional, psychological or mental domains. Marital 
status is a patient factor which would be expected to contribute to emotional,
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psychological, mental or social domains of quality of life. It is unlikely to affect 
physical functioning and therefore will not contribute to quality of life if an 
instrument measuring predominantly physical outcomes is used.
The HADS was the only instrument which was affected by age, gender, marital 
status, co-morbidity and NYHA class. Psychological wellbeing is therefore highly 
influenced by disease, demographic and social factors. This is supported by 
previous research. Gott et al also found that depression was significantly 
associated with all quality of life outcomes.(Gott et al. 2006) A study examining 
quality of life in patients with heart failure (n=58) found that depressive 
symptoms had a greater impact on quality of life than severity of cardiac 
dysfunction or functional impairment.(Carels 2004) Further evidence suggests 
that patients with depression report a higher number of physical symptoms 
which in turn is associated with a decrease in quality of life.(Bekelman et al. 
2007)
The disease specific MLwHF measures both physical and emotional dimensions 
of quality of life but did not show association with all the independent variables. 
Although there is substantial evidence of the reliability and validity of the 
MLwHF, Heo et al showed that its psychometric soundness could be improved 
with the removal of several items. (Heo et al. 2005)
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NY HA Class/Disease severity
The strong association between NYHA class and quality of life is consistent with 
the findings of previous research in quality of life of patients with heart failure. 
Higher NYHA class was associated with a reduced quality of life in patients with 
heart failure in general practice in Northern Ireland. This finding is supported by 
several previous studies in secondary care (Hobbs et al. 2002, Juenger et al. 
2002, Carols 2004) and in a study recruiting patients from general practice. (Gott 
et al. 2006) Gott et al found that in patients with heart failure recruited from 
general practice NYHA class was significantly associated with all quality of life 
outcomes, a finding confirmed by our study.
Increasing disease severity, as measured by NYHA class, has a detrimental 
effect on both physical and emotional components, as well as disease specific 
and generic quality of life issues. As disease severity increases patients would 
be expected to have a higher symptom burden and therefore greater functional 
limitation, leading to a global reduction in quality of life. This model would 
explain how NYHA class is significantly associated with quality of life and 
psychological wellbeing, irrespective of the instrument used. Hobbs et al found 
that this relationship can be influenced. By optimising treatment to improve 




The use of patient reported NYHA class as a marker of disease severity is not 
without flaws. By asking patients to grade their own NYHA class it could be 
argued that this is an indirect indication of how they view their quality of life. If 
this is the case then self-reported NYHA class and quality of life are 
synonymous.
Patient reported NYHA class may also not be a true reflection of disease 
severity or functional limitations. Patients rate their NYHA class higher than 
nurses.(Karlsson et al. 2008) The discrepancy between nurse and patient NYHA 
assessment has been shown to be associated with the patients degree of 
depression.(Karlsson et al. 2008) General practitioners do not routinely record 
NYHA in patient notes therefore patient reported NYHA class was necessary in 
this study. Despite the flaws in using patient reported NYHA class, patients' 
perceptions of functional status and their influence on quality of life are 
important, even if it is not an accurate measure of disease severity.
The effects of heart failure on quality of life can be attributed to symptoms 
(Rector, Anand & Cohn 2006), the stage of heart failure (Azevedo et al. 2008) 
and NYHA class (Hobbs et al. 2002). However the regression models show that 
the variation in quality of life scores in patients with heart failure may also be 




Increasing levels of co-morbidity were associated with poorer outcomes on all 
instruments used. Co-morbidity was a significant confounder in all 
questionnaires except for the SF-12 MCS indicating that the level of co-morbidity 
not only impacts upon the physical and emotional domains of quality of life, but 
also on the degree of depressive and anxiety symptoms in patients with heart 
failure. Patients with 4 or more conditions had the poorest outcomes on all 
measures. These results correspond to findings from previous research. (Gott et 
al. 2006)
Co-morbidity would be expected to impact upon quality of life scores obtained 
from generic quality of life instruments. By their nature generic instruments aim 
to obtain an overall impression of quality of life across all domains and 
conditions. A greater number of co-morbid conditions would result in a greater 
range of possible quality of life effects and therefore poorer outcomes on a 
generic instrument. Although increasing level of co-morbidity resulted in poorer 
outcomes on the generic SF-12 MCS, it was not a significant contributor in the 
regression model. This could be explained by the domains included in the MCS. 
It measures mental components of quality of life which would be less likely to be 
influenced by multiple physical conditions than the SF-12 PCS in which co­
morbidity was a significant contributor. Flowever, the presence of co-morbid 
conditions was a contributor to the variation in the total FIADS score and is
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therefore associated with impaired psychological wellbeing in heart failure 
patients.
Interestingly co-morbidity was also a significant confounder in the MLwHF, a 
disease specific instrument. This instrument was designed to measure the 
effects of heart failure on an individuals’ quality of life. The relationship between 
co-morbidity and heart failure disease specific quality of life is likely to be 
complex. Co-morbid conditions may not only produce similar symptoms to heart 
failure but the global impact of multi-morbidity may also play a role in affecting 
the domains included in the disease specific tool. In their study Gott et al also 
found that disease specific quality of life was influenced by co-morbidity.
Patients in this study with four or more co-morbid conditions had much lower 
scores on the Kansas City Cardiomyopathy Questionnaire than those with one 
or no co-morbid conditions.
Patients with heart failure report a wide range of individual co-morbid conditions. 
The most common co-morbid condition reported was arthritis, although the type 
of arthritis was not clarified it is likely that patients were reporting osteoarthritis 
due to the age of the study cohort. Visual and hearing impairment would be 
relatively common in elderly patients. With the mean participant age of 73 years, 
it is hardly surprising that this was the second most common condition with 
38.9% of participants reporting it as a co-morbid condition. The high prevalence 
of angina and lung disease in the study participants is to be expected given the 
aetiology of heart failure and the risk factors for its development. Very few
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patients (4%) reported mental health disorders as a co-morbid condition despite 
the high levels of depression and anxiety on the HADS. This indicates that 
although heart failure patients suffer from depression and anxiety, few are given 
such a diagnosis. This highlights the need for healthcare professionals to be 
vigilant and screen for depression and anxiety in heart failure patients. 
Recognition and treatment of these conditions could improve the quality of life of 
patients with heart failure. The association of arthritis, blood disorders, gastro­
intestinal disease in two of the four instruments could be due to the fact that 
these conditions were some of the most prevalent in study participants. Many of 
the co-morbid conditions were present in insufficient numbers to analyse. For 
example, psychiatric conditions were also associated with quality of life 





Single patients in this study had better outcomes in the disease specific and 
generic instruments as well as the HADS. In previous quality of life studies in 
patients with heart failure recruited from the community the impact of marital 
status was not explored. However a study examining heart failure mortality 
found that the presence of a relationship and its quality was a predictor of 8 year 
survival. (Rohrbaugh, Shoham & Coyne 2006) The presence of a life partner 
would be expected to contribute favourably to the social domains in quality of life 
instruments. However the presence of a poor relationship at home could also 
have a detrimental effect on quality of life and therefore being single could be 
protective. The number of single patients in the study was small (n=9) and 
therefore this could just be a spurious finding. Participants who were married or 
had a partner had better quality of life outcomes than those who were widowed 
who in turn had better outcomes than those who were divorced or separated. 
This does suggest personal relationships have some influence on quality of life. 
Marital status did not contribute to PCS outcomes, the only instrument which 
solely measured the physical component of quality of life. This indicates that the 
influence of marital status on quality of life of patients with heart failure appears 




Increasing age was associated with better quality of life, particularly in the 
disease specific instrument and in those which measured mental and 
psychological domains. The study hypothesis postulated that increasing age 
would be associated with poorer quality of life. The rationale for this was that 
elderly patients are more likely to have co-morbidity and higher levels of 
baseline disability than younger patients with heart failure. In addition to this 
many elderly patients have less social support and the combination of these 
factors was expected to be reflected in poorer quality of life scores. The poor 
representation of older patients in clinical trials in heart failure limits the 
availability of data on quality of life in elderly patients. The evidence which is 
available from previous research regarding age and quality of life in patients with 
heart failure is also conflicting.
In their study, recruiting patients over 60 years old with heart failure from primary 
care, Gott et al found that increasing age was associated with poorer quality of 
life outcomes. Older patients had lower scores on the physical and mental 
functioning scales of the SF-36 than the younger patients in this study but no 
association between age and disease specific quality of life was found. The 
median age of participants in this study was 77 years, a much older cohort than 
our study in which the median age was 74 years. The recruitment of patients 
exclusively over the age of 60 years could explain the discrepancy between this 
study’s results and others reported in the literature.
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An evaluation of the functional capacity and health related quality of life in 
patients (n=546) with heart failure from secondary care reported similar findings 
to our study. (Masoudi et al. 2004) Despite older patients in this study having 
higher NYHA classes and poorer functional capacities on a 6-minute walk test, 
they reported better quality of life outcomes at baseline than the younger 
patients. One disease specific instrument was used in this study, the Kansas 
City Cardiomyopathy Questionnaire. The MLwHF was used in a study 
performed in secondary care which also reported a significant association 
between age and better disease specific quality of life. (Rector, Anand & Cohn 
2006)
Increasing age in the study was associated with increasing levels of co-morbidity 
(p=0.04) but there was no significant difference in NYHA class of older patients 
compared to younger patients. Despite this increasing age was associated with 
better quality of life. This suggests that although older patients with heart failure 
have similar functional capabilities to younger patients and higher levels of co­
morbidity, these factors do not have as significant an effect on their quality of 
life. The acceptance of functional limitations may be one reason for this finding. 
Older patients may have lower expectations of acceptable levels of function. 
Therefore functional limitations have less impact on their reported quality of life. 
Younger patients on the other hand may feel more frustrated by reduced levels 




Although, there was no significant difference between the gender of the 
responders and non-responders, females had a poorer response rate than 
males. Despite more females invited to participate in the study, the majority of 
respondents in the study were male. Gott et al also reported poorer response 
rates in women than in men. (Gott et al. 2006)
Females had poorer quality of life outcomes than males on the PCS, the MCS 
and the HADS. Other studies have reported poorer quality of life outcomes in 
women. (Friedman 2003, Stomberg, Martensson 2003) However like older 
patients with heart failure, women tend to be underrepresented in clinical trials 
(Heiat, Gross & Krumholz 2002, Krumholz 1998) and therefore conclusive 
evidence on the effect of gender on quality of life is not available. Rector et al 
was one such study which found no significant association between gender and 
quality of life. (Rector, Anand & Cohn 2006) Gott et al aimed to identify factors 
predictive of quality of life amongst older patients recruited from community 
settings. They found that women had poorer quality of life outcomes on the 
disease specific measure used and the SF-36 PCS but not the SF-36 MCS.(Gott 
et al. 2006) In contrast we found that females had poorer outcomes on both the 
SF-12 PCS and MCS as well as the HADS, but not on the disease specific 




Being female was associated with poorer quality of life and in particular greater 
psychological morbidity. This suggests that female patients with heart failure are 
more sensitive to the impact of disease on mental and emotional health. The 
exact mechanism by which gender affects quality of life is not known and further 




An unexpected finding of our study was the lack of association between social 
class and quality of life outcomes. In previous research in primary care 
socioeconomic group was significantly associated with disease specific and 
generic mental health scale but not with the generic physical functioning scale
Social class, as measured by the MDM score was not associated with quality of 
life or psychological distress in heart failure patients recruited from general 
practice in Northern Ireland. There was no significant difference in social class 
between the respondents and non-respondents but the heart failure population 
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Histograms showing the distribution of MDM score in the all patients sent the 
study information (above) and those who responded (below).
As illustrated in Figure 20 the majority of the population sampled and the final 
study population were in the lower MDM score brackets. This could be due to a 
higher prevalence of heart failure in lower socioeconomic groups or an 
unrepresentative sample in this study. However the lack of patients in the higher 
socioeconomic groups could explain the lack of association with quality of life. 
Perhaps the range of socioeconomic groups was not great enough to 
demonstrate a significant difference.
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Discussion of results from stage 2 of study
Despite the limitation of our qualitative data the themes identified from the 
interviews were consistent with previous findings in patients with heart failure 
and chronic disease. The effects of functional limitations and symptoms of heart 
failure on quality of life are well known. A local qualitative study identified that 
patients with chronic illness face many difficulties due to deteriorating health 
status including decreased independence and social isolation. The patients in 
this study were found to have various unmet needs and had difficulty in 
accessing community services. (Fitzsimons et al. 2007)
The patients interviewed recognised the vital role of specialist heart failure 
support services, particularly heart failure nurses, in improving quality of life.
Rich et al reported that patient education programmes, particularly heart failure 
nurse led interventions, had positive influences on quality of life outcomes. (Rich 
et al. 1995) In addition to this the support of heart failure nurses has been shown 
to positively influence levels of depression. (Martensson et al. 2005)
A strong theme which emerged from our interviews was the lack of effective 
communication between healthcare professionals and patients with heart failure. 
Communication was found to be lacking at the time of diagnosis, during hospital 
stays and when discussing prognosis.
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“Most people with heart failure do not understand the cause or prognosis of their 
disease and rarely discuss end of life issues with their professional carers.” 
(Murray et al. 2002)
In this community based qualitative study Murray et al found that patients with 
heart failure had a poorer understanding of their condition and prognosis and 
were less autonomous than those with lung cancer.
The need for better communication in heart failure was also highlighted by 
Rogers et al who reported that communication with heart failure patients and 
their subsequent understanding of their condition and symptoms was 
lacking.(Rogers et al. 2000) In a multicentre, post-hospitalisation interview study 
of heart failure patients in Slovenia n = 187, 89% were aware of their condition 
but only 61% reported satisfaction with the communication received regarding 
their clinical condition from medical staff.(Lainscak, Keber 2003) Patients also 
identified difficulties in communicating with doctors as a potential barrier to 
receiving appropriate information regarding prognosis.(Rogers et al. 2000)
The quantitative and qualitative findings of the study both highlight the poor 
quality of life in patients with heart failure. This may be adversely affected by 
disease severity, age, gender and co-morbidity but can also be positively 
influenced by the actions of doctors and other healthcare professionals. Patients 
have identified key areas which have helped them cope with their illness and 
these are supported in the literature. In addition to good quality medical care,
Page
144
access to support services, contact with heart failure nurses, good 
communication and a holistic approach to heart failure management are areas 
which can make a difference to the patients’ quality of life.
Individual patients with heart failure have different quality of life issues and 
unmet needs. It is therefore vital that care is tailored to the individual. There is 
evidence that patients with heart failure have as poor a prognosis and symptom 
burden as patients with cancer. (Nordgren, Sorensen 2003, Stewart et al. 2001) 
Heart failure patients also report similar problems to patients with conditions 
managed by palliative care teams, such as uncontrolled symptoms, progressive 
decline, dependence and poor quality of life. However, traditionally patients with 
heart failure have been unlikely to receive specialist palliative care. The 
importance of palliative care in heart failure management is beginning to be 
recognised. The National Service Framework for Coronary Heart disease 
(Department of Health 2000) identified the need for patients with unresponsive 
heart failure to receive appropriate palliative care. This can be challenging to 
implement in the community with one barrier being general practitioners 
reluctance to initiate due to difficulties in accurately predicting prognosis in heart 
failure. (Hanratty et al. 2002)
The principles of palliative care can be used to improve quality of life in patients 
with varying severity of heart failure. The centre of this treatment model is good 
communication, identified as a problem area in our study interviews. General 
practitioners and hospital doctors need to recognise the importance of
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combining treatment modalities with the holistic approach of palliative care and 
at the same time keeping the patient informed and involved. The introduction of 
earlier access to support for patients and their families can reduce the feelings 
of burden and make functional limitations less disabling.
Improvements in quality of life can be achieved through better symptom control 
by adjusting medical therapy but patients and their families also require the 
support to help them cope with the daily burden of this disease. For example 
involving healthcare professionals such as nursing care, social workers, and 
occupational therapists to address social care needs and improve quality of life. 
The qualitative interviews indicate that it is these services which patients and 
their families value the most. Although valuable data was gathered from these 
interviews further work in this area is required.
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Strengths of the study
This study highlights the impact of heart failure on quality of life and how unmet 
needs influence the daily life of individuals with heart failure and their families. 
Despite providing data on an area of clinical importance it is also the first study 
of its kind in general practice in Northern Ireland and provides valuable 
information which was not previously available.
Previous studies in general practice have been limited due to the difficulty in 
identifying patients with an accurate diagnosis of heart failure. The introduction 
of heart failure registers, which require an objective measure of heart failure 
allowed this study to recruit patients from primary care with a definite diagnosis. 
Patients under the age of 18 years were excluded but all other age groups were 
included. Previous studies in secondary care often excluded these older 
patients. It is the first study of quality of life in heart failure patients recruited from 
the community to report increasing quality of life with increasing age.
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Limitations of the study
The main limitations of this study are the cross-sectional design and the small 
study size. The sample size calculation was based on the likely effect size for 
the MLwHF and although this sample size was achieved, the total study 
population was still small given the cross-sectional design.
Despite the results showing that there were no significant differences in the 
respondents and non-respondents in this study, there may have been selection 
bias. The patients who responded to the questionnaire survey may have been 
more motivated and had a better quality of life than those who did not respond.
The NYHA class for each patient was obtained from the demographic 
questionnaire. A NYHA scale in lay terms was included and patients were asked 
to select the class which best applied to them. There may be an overlap in the 
self-reported NYHA class and the perceived quality of life. The use of this 
method to indicate disease severity may therefore be flawed.
The MLwHF is validated as a complete tool, the individual questions and 
subscales cannot be used in isolation. Although it was designed to measure the 
effect of heart failure on quality of life it may have been difficult for patients to 
separate the symptoms of heart failure and any co-morbidities.
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A question on the MLwHF regarding the influence of heart failure on work ability 
caused some confusion. Many patients omitted this question as they were past 
retirement age. Therefore these individuals may have had lower overall scores 
than patients of working age.
The finding that single patients had better quality of life outcomes than those in 
all other marital groups was an interesting observation. However the small 
sample size and in particular the small number in this group, limited the ability to 
analyse this in greater detail.
Heart failure registers allowed identification of patients with a confirmed 
diagnosis of heart failure. The strength of the study data could have been 
improved by obtaining an objective measurement of cardiac function form the 
patients’ medical records. Although the consent forms allowed this to be done, 
time constraints limited the collection of this data.
Time constraints also inhibited collection of more data in stage 2 of the study. 
Data saturation was not achieved in the qualitative interviews. As a result the 
qualitative data can only be used to inform the stage one data and provide a 
focus for further research in this area.
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Conclusions of questionnaire survey
Quality of life in patients with heart failure varies greatly and is dependent on 
disease and patient factors. The quality of life instruments used in this study 
obtained information on a variety of quality of life domains and concepts and 
demonstrated that different disease and patient factors are important depending 
on the instrument used (See Table 6).
Disease severity, as measured by self-reported NYHA class was the most 
significant independent variable. Higher NYHA class resulted in detrimental 
effects on both physical and emotional components, as well as disease specific 
and generic quality of life areas. However NYHA class may not be a reliable 
marker of disease severity and may indirectly represent quality of life if self- 
reported by patients.
Patients with heart failure recruited from general practice have high levels of co­
morbidity (77% of participants had 2 or more co-morbid conditions) and a wide 
range of individual co-morbid conditions. Increasing levels of co-morbidity are 
associated with poorer quality of life outcomes in patients with heart failure . Co­
morbidity has a detrimental effect on physical quality of life in patients with heart 




Marital status contributes to quality of life in patients with heart failure. It was a 
significant contributor to quality of life outcomes in the MLwHF, the SF-12 MCS 
and the FIADS. Marital status did not contribute to PCS outcomes, the only 
instrument which solely measured the physical component of quality of life. 
Single patients in this study had better quality of life outcomes than those who 
were married or lived with a partner but the number of single patients was small. 
Those who were widowed, divorced or separated had much poorer outcomes 
than the participants who were single or in a relationship. Marital status 
therefore contributes to quality of life in heart failure patients, but appears to 
affect social and emotional domains more than physical domains.
The average age of patients in the study was 73 years, with the oldest 
participant aged 90 years. Age was found to contribute to variation in the 
MLwHF, the MCS and the HADS scores. The older participants in the study had 
better results in terms of quality of life and psychological wellbeing than younger 
participants. This may be due to older patients accepting functional limitations 
and having lower expectations of physical and emotional health.
Social class, as measured by the MDM score was not associated with quality of 
life or psychological distress in heart failure patients recruited from general 
practice in Northern Ireland.
Despite inviting more females to participate in the study, the majority of 
respondents in the study were male. Gender was found to be a contributing
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factor in the PCS, the MCS and the HADS. It was not a significant confounder in 
the disease specific instrument, the MLwHF. Being female was associated with 
poorer quality of life and in particular greater mental and psychological morbidity 
in patients with heart failure.
Quality of life and psychological wellbeing in patients with heart failure is closely 
associated with disease severity and the presence of co-morbid conditions. 
Patients who are widowed, divorced or separated have poorer outcomes than 
those who are single or in relationships and females have poorer quality of life 
than males. Younger patients report poorer quality of life and more 
psychological distress than older patients.
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Conclusion of patient interviews
Patients with advanced heart failure (NYHA class IV) report significant functional 
limitations and have complex unmet needs. The symptoms of heart failure and 
the progressive disease process results in reduced levels of physical and 
emotional functioning. As a result of this patients experience a loss of sense of 
self and of traditional roles. They become increasingly dependent on family and 
partners and this may result in feelings of guilt. Other consequences of 
increasing functional limitation include the inability to work and the impact on 
finances, travel and leisure.
The quality of life of patients with heart failure and their functional limitations 
may be improved through high quality, holistic multidisciplinary care. Patients 
value the input of heart failure nurses and support services which help maintain 
their independence. Patients with heart failure have fears for the future and they 




Chapter 7 - Summary of Thesis
Introduction
• Congestive heart failure is a clinical condition which results in significant 
morbidity and mortality.
• The incidence of heart failure is directly associated with increasing age. 
As life expectancy in the United Kingdom is increasing the incidence of 
heart failure is expected to rise.
• Heart failure has a detrimental effect on quality of life. The symptoms of 
heart failure explain a large proportion of variation in quality of life but 
other demographic variables are thought to also contribute.
• Quality of life is both subjective and multidimensional. It must be 
measured from the patient’s perspective and information on various 
aspects of a patient’s life is required for its adequate assessment. 
Questionnaires are a useful tool in measuring quality of life and may be 
generic or disease specific in nature.
• Most of the quality of life data for patients with heart failure has been 
obtained from trials in secondary care. Women, older patients and those 
with co-morbidity are under-represented in these studies. There are few 




• The introduction of the Quality and Outcomes Framework in general 
practice has improved the need for a definite diagnosis of heart failure 
using objective measures and the recording of heart failure in patients 
records. This facilitates more accurate identification of patients with heart 
failure for research.
• Qualitative research exploring quality of life in heart failure has shown 
patients recognise the impact of positive and negative influences on 
quality of life.
• The needs of patients with advanced chronic disease, such as heart 
failure, are complex and a more timely implementation of palliative care is 




• Nine practices in Northern Ireland participated in a study which aimed to 
explore quality of life and unmet needs of patients with heart failure 
recruited from the community.
• 297 patients with heart failure were invited to participate in the study and 
90 responded. The study response rate was 30.3%.
• The mean age of participants was 73 years, the study population had 
more males than females, the most common NYHA classes were II and 
III and most patients were married or lived with a partner. Over 77% of 
participants had 2 or more co-morbid conditions.
• There were no significant difference between the respondents and non­
respondents in terms of age (p=0.827), gender (p=0.274) and social 
class(p=0.383).
• Patients in NYHA classes I and II had significantly better quality of life 
scores on the MLwHF (p<0.001), the SF-12 PCS (p<0.001) and the SF- 
12 MCS (p<0.001) than those in NYHA classes III and IV.
• Patients in NYHA classes I and II also had significantly lower levels of 
psychological morbidity on the HADS (p<0.001) than those in NYHA 
classes III and IV.
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• The disease, demographic and social factors included in this study were 
responsible for 55% of the variation in quality of life scores measured by 
the disease specific MLwHF questionnaire.
• The variables which contributed to MLwHF scores were NYHA class, 
age, co-morbidity and marital status. Those with lower NYHA class, older 
patients, those with fewer co-morbid conditions and single patients had 
better quality of life as measured by the MLwHF.
• The independent variables used in the study were responsible for 49% of 
the variation in SF-12 PCS scores.
• The variables which contributed to SF-12 PCS scores were NYHA class, 
gender and co-morbidity. Those with lower NYHA class, male patients 
and those with lower levels of co-morbidity had better quality of life as 
measured by the SF-12 PCS.
• The independent variables used in the study were responsible for 36% of 
the variation in SF-12 MCS scores.
• The variables which contributed to SF-12 MCS scores were NYHA class, 
age, gender, and marital status. Those with lower NYHA class, older 
patients, males and single patients had better quality of life as measured 
by the SF-12 MCS.
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• The independent variables used in the study contributed to 48% of the 
variation in HADS scores.
• The variables which contributed to HADS scores were NYHA class, age, 
gender, co-morbidity and marital status. Those with lower NYHA class, 
older patients, males, those with lower levels of co-morbidity and single 
patients had better psychological wellbeing as measured by the HADS.
• Symptoms of heart failure and the resulting functional limitations are the 
core negative influences on quality of life in patients with heart failure.
• Patients reported that these core influences impact on quality of life 
through dependence, loss of sense of self and roles, an inability to work, 
inability to perform activities of daily living and enjoy leisure and travel.
• Personal relationships and good family support are important in helping 
patients cope with the impact of heart failure on quality of life. However 
dependence on partners and families may result in feelings of guilt for 
patients with heart failure.
• Positive influences which can help improve quality of life for patients with 
heart failure include good GP and hospital care, social support, the 
availability of heart failure nurses, the use of holistic or palliative care, 





• Quality of life in patients with heart failure varies greatly and is dependent 
on disease, patient factors and the instrument which is used to assess it.
• Disease specific quality of life in patients with heart failure in Northern 
Ireland is affected by disease severity, age, co-morbidity and marital 
status.
• The physical and mental components of quality of life in patients with 
heart failure using a generic tool are affected by disease severity, gender 
and disease severity
• Psychological wellbeing in patients with heart failure is affected by 
disease severity, age, gender, NYHA class, level of co-morbidity and 
marital status.
• Disease severity, as measured by self-reported NYHA class was the 
most significant independent variable. Higher NYHA class resulted in 
detrimental effects on quality of life measured by all instruments. NYHA 
class may not be a reliable marker of disease severity and may indirectly 
represent quality of life if self-reported by patients.
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• Patients with heart failure recruited from general practice have high levels 
of co-morbidity and increasing levels of co-morbidity are associated with 
poorer quality of life outcomes.
• Marital status contributes to quality of life in patients with heart failure. 
Single patients in this study had better quality of life outcomes and those 
who were divorced or separated had the poorest outcomes. The number 
of single patients was however small. Marital status affects social and 
emotional domains of quality of life more than physical domains.
• Older patients with heart failure have better outcomes in terms of quality 
of life and psychological wellbeing than younger patients. This may be 
due to older patients’ acceptance of functional limitations and lower 
expectations of physical and emotional health.
• Female patients with heart failure have a poorer quality of life than males, 
especially in the mental domains.
• Patients with advanced heart failure (NYHA class IV) report significant 
functional limitations and have complex unmet needs.
• The quality of life of patients with heart failure and their functional 
limitations may be improved through high quality, holistic multidisciplinary 




Previous studies examining quality of life of patients with heart failure in the 
community were limited due to difficulties with recruitment. Despite using heart 
failure registers to accurately identify patients, our study was limited by its small 
sample size. Therefore a larger cross sectional or longitudinal study exploring 
quality of life in patients with heart failure recruited from community heart failure 
registers is required.
Unmet needs in patients with heart failure need addressed to improve standards 
of care. To determine the needs which are important to patients a larger 
qualitative study is required. This should include both a wide range of patients 




Appendix 1 Practice Invitation Letter




Following your conversation with Dr. Gilliland, we are conducting a study 
exploring quality of life and unmet needs of heart failure patients in primary care 
and wish to invite your practice’s participation. The practice has been selected 
as one often general practices from across Northern Ireland.
Study title: Exploring quality of life and unmet needs of patients with heart 
failure in a General Practice population.
The aims of this study are to gather quality of life data from heart failure patients 
in primary care across Northern Ireland and assess unmet needs of a small 
group of these patients through individual qualitative interviews.
The primary investigator is Dr. Martina Monaghan, research registrar in General 
Practice, supervised by Dr. A. Gilliland and Dr. M. Guppies at Queen’s 
University Belfast.
Please find enclosed a pack including practice and patient information sheets 
and the practice reply slip. We would be grateful if you could indicate whether or 




Dr Martina Monaghan/ Dr Drew Gilliland/ Dr Margaret Guppies








Appendix 2 Practice Information Sheet
Exploring quality of life and unmet needs of patients with heart failure in a 
General Practice population
PRACTICE INFORMATION SHEET
Rationale and study objectives
Congestive heart failure is a condition which results in considerable morbidity 
and mortality. 1 The detrimental effect of heart failure on quality of life has been 
recognised for many years 2 with quality of life data being collected through 
clinical trials in secondary care. However, due to pressure on secondary care 
services, heart failure patients are now increasingly being managed in primary 
care. This study will obtain quality of life data from patients with heart failure of 
varying severity (New York Heart Association Classes 1-4) in the Northern 
Ireland General Practice population.
There is evidence that patients with heart failure currently receive sub-optimal 
levels of supportive care and have complex unmet needs.3,4 This study aims to 
determine patients’ unmet needs through semi-structured interviews. This 
information is not available currently for General Practice patients in Northern 
Ireland and is necessary if care for this group of patients is to be improved.
What will happen if our practice agrees to participate in this study?
1. If you agree to participate you will firstly be asked to identify patients with 
heart failure from your disease register who fulfil the study inclusion 
criteria. These are as follows;
• Patients with diagnosis of heart failure as identified from practice 
heart failure register.
• Age greater than 18 years
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• Physically able to complete a questionnaire
• No evidence of cognitive dysfunction
• Able to consent to participation in study
• English speaking
2. The practice will be provided with prepared study information packs which 
include the following documents:
• Information for patient on background and aims of study
• Question sheet on patient factors e.g. age, sex, postcode, marital 
status, co-morbidities and perceived NYHA class.
• Short - Form 12 (SF-12) quality of life questionnaire
• Flospital Anxiety and Depression scale (FIADS)
• Minnesota Living with Fleart Failure Questionnaire (MLwHF)
• Consent forms for;
- Access to patient’s medical records
- Willingness to be contacted by the researcher for further discussion 
of experiences in second stage of the study
• Stamped addressed envelope for return of survey to researcher
The questionnaires should take no more than 30 minutes in total to complete.
3. These information packs would be sent to the identified patients by the 
practice. (Postage costs will be covered by the research team)
4. If a patient from the practice consents to participate their medical records 
would be viewed by the researcher Dr Martina Monaghan at a mutually 
convenient date and time. Only information pertinent to the study will be 
used.
5. If a patient does not wish to participate we will ask for some basic 
anonymised data to analyse for possible response bias. This information 
would be limited to age, gender and postcode.
Please see the patient information leaflet for further information and if you have 
any queries do not hesitate to contact the research team at the number below.
Dr Martina Monaghan 
Department of General Practice 








(1) Davis RC, Hobbs FDR and Lip GYH. ABC of Heart Failure: history and epidemiology. BMJ 
2000; 320: 39-42.
(2) Hinton JM. The physical and mental stress of dying. QJM 1963; 32: 1-21.
(3) Ward C. The need for palliative care in the management of heart failure. Heart 2002; 87: 
294-298.
(4) Fitzsimons et al. The challenge of patients’ unmet care needs in the final stages of chronic 
illness. Palliative Medicine 2007; 21: 313-322.
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Appendix 3 Practice consent form
GP reply slip
Practice name
We would like to participate in this study
We do not wish to participate in this study
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Appendix 4 Practice Reminder letter
Dr. X and Partners 
Practice Address
Date
Dear Dr. X and Partners
Further to the letter we sent you on (Date), please find enclosed a copy of this 
letter and a reply slip. We would be grateful if you could indicate whether or not 
you wish to participate in this study.
Many Thanks,
Dr Martina Monaghan/ Dr Drew Gilliland/ Dr Margaret Guppies








Appendix 5 Participant invitation letter




The practice is involved in a study being carried out by Dr. Martina Monaghan at 
Queen’s University, Belfast.
The study aims to find out how people’s lives are affected by heart trouble. 
Patients with all types of heart trouble are being invited to take part by 
answering the questionnaires enclosed and returning them in the pre-paid 
envelope provided.
It is hoped that the results of this study will highlight how heart trouble affects 
individuals’ lives and identify areas in which care could be improved.
If you would like to take part in this questionnaire study please read the 
information leaflet enclosed and return your completed forms in the pre-paid 
envelope. Thank you for taking the time to read this letter. If you have any 
questions about the study feel free to contact Dr. Monaghan at the number 
below. If you decide not to take part in the study your medical care will not be 
affected and your personal details will not be released to the researchers.
Yours sincerely,
Dr. X and Partners
Dr. Martina Monaghan 
Department of General Practice 
Dunluce Health Centre 






Appendix 6 Participant information sheet
Study title: Quality of life and needs of patients with heart trouble
Dear
My name is Dr. Martina Monaghan. I am a medical doctor currently enrolled in a 
master’s course in research at Queen’s University, Belfast.
You have been invited to take part in this study looking at how heart trouble 
affects people’s lives. Before you decide to participate it is important for you to 
understand why the study is being carried out and what it involves. Please read 
the following information and discuss it with others if you wish. If anything is 
unclear, or if you would like more information please contact me at the following 
number - 02890204301.
What is the purpose of the study?
I am doing this study to find out how heart trouble affects people’s daily lives and 
how they feel their care could be improved.
Why have I been chosen?
Your GP practice has agreed to take part in this study and has been asked to 
forward this information to patients in their practice with a history of heart 
trouble.
What are the benefits of taking part?
Although there is no direct benefit to you by participating in the study, by taking 
part you will be helping us understand more about how heart disease affects 
people’s lives. The answers to your questions will give us valuable information 
about this. Through the results of this study we hope that doctors will have a 
greater insight into what is important to the patient with heart trouble and we 
may be able to make suggestions to improve care.
What will happen to me if I take part?
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1. On the following pages are some questions about yourself and how heart 
trouble affects your daily life. Please answer all these questions as best 
you can and return them with the consent form in the envelope provided. 
The questions should take about 20-30 minutes to complete. If you wish 
this is all you have to do.
2. As part of the study a small number of people will be selected to discuss 
areas were they feel their needs are not being met. I will visit these 
patients in their own home at a time which suits them. If you do not wish 
to be involved in this part of the study please tick the relevant box on the 
consent form. Unfortunately not everyone who is interested in being 
involved in this part of the study will be selected initially but there may be 
the opportunity to involve more people at a later date.
3. On the consent form you will notice I have asked for your permission to 
access your records at the practice. This is important so I can identify 
your type of heart trouble and any other medical conditions which could 
affect you, for example lung disease, diabetes etc
What will happen if I don’t take part?
Your participation in this study is entirely voluntary. If you decide not to take part 
or if you later decide to withdraw from the study at any time:
• You can do so freely without obligation
• You do not have to give a reason
• Your care will not be affected in any way
Will my information be kept confidential?
All information relevant to you will be treated confidentially and recorded 
anonymously. However, if you reveal some information that causes the 
researcher to be concerned regarding your welfare, this may need to be 
discussed with your own GP.
What happens to the results of this study?
I hope to eventually get the results of this study published. In any report or 
publication of the study results, you will not be identified.
Who is organising the research?
This research is taking place at the Department of General Practice, Queens 
University of Belfast. The study is funded by the Research and Development 
office, Northern Ireland.
What should I do now?
If you would like to participate, please:
• Answer the questions on the foillowing pages
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• Sign the consent form and indicate whether you wish to be considered for 
the later discussion
• Return both in the envelope provided
If you have any questions or difficulties in answering the questions please do not 
hesitate to contact me using the details below.
Complaints
If you have a concern about any aspect of this study, you should speak to the 
researcher whose details are provided below. If you remain unhappy or do not 
wish the researcher to be aware of your complaint, you can complain through 
the NHS complaints procedure
Dr. M. Monaghan 
Research Registrar 
Department of General Practice 
Queen’s University Belfast 







Appendix 7 Participant consent form
STUDY CONSENT FORM
I............................................................ have read the information and
agree to participate in this study. I understand I can withdraw at any 
time. I give my permission for my medical notes to be 
viewed by the researcher.
Signed...............................................
Date...................................................
Please state below whether you would like to be involved in further 
discussion about how heart trouble affects your daily life, as detailed 
in the information sheet.
I would be willing to discuss my experiences with Dr. Monaghan at a 
later date




Appendix 8 Participant demographic questionnaire
Demographic questionnaire
Thank you for deciding to take part in this study. On the following pages are 
some questions about how your heart trouble may impact on your everyday life. 
Before completing these it is important for us to know a little bit about you.
The information you provide will be kept confidential and will only be used for the 





Marital status Single □
Married □ 
Widowed □
Live with partner □ 
Divorced □ 
SeperatedD
Do you have any other health problems? Please tick as many of the boxes 
below which apply to you. If you suffer from a health problem which is not 









□ HearingA/isual impairment □
□ Cancer □
□ Stroke/ Brain disorder □





Which of the following categories would best describe how your heart 
trouble impacts on your level of activity:
I have no problems performing normal physical activity □
I am comfortable at rest but ordinary activity makes me breathless and tired □
I am comfortable at rest but less than ordinary activity makes me breathless and 
tired □






Appendix 11 The Short-Form 12
Your Health and Well-Being
This survey asks for your views about your health. This information still help 
keep track of how you feel and how well you are able to do your usual activities. 
Thank you for completing this survey’.
For each of the following questions, please tick the one box that best desciibes 
vour answer.
1. In general, would you say your health is:
Excellent Very good Good Fair Poor
▼ ▼ ▼ ▼ ▼
□ . □ . □ □ «
2. The foliosting questions are about activities you might do during a typical 
day. Does t our health now limit you in these actisities? If so. how much?
Moderate activities, such as mosing a table, pushing 
a vacuum cleaner bcwhng. or piaymg golf______
Ckmbuig several fhgfcts of stairs „ ........ ........... .......
Yes. Yes. No. not
limited limited limited
a lot a littie at all
▼ ▼ ▼
.. .....  □ = • .......□'
□ ..... .......□ -
iF-Ih-"™ SncrprLSS2-2002 br Lsfc. Cirt-araK 7iuii szcQBriK^fiMnc larcipccrwi AI nzkn u.iz- ad
xF-U« ::msuftcsc nimmA sf Madcd. Zutoxaas 7m.ii 
T^OLA. SF-:fr2 S—ifawl Ecatd: (UsradKgyfac) • 3T;
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3. During the past 4 weeks, bow much of the time have you had any of the 
following problems with yonr work or other regular daily arthiries as a 
result of voor physical health?
All of Most of Some of A little of None of
lietnce the time the tnae die tide ±e tnae
▼ ▼ ▼ ▼ ▼
Accomplished Less than voit
wiouldlike............. .............. XL □ >_____ XL.....—a*
Were limited in the laid of 
woii or other activities........... □ •........... XI. □ >_____ .....-.a.
4. Duiing the past 4 weeks, how much of the time have you bad any of the 
following problems with your work or other regular daily activities as a 
tesult of any emotional problems (such as feeling depi essed or anxious)?
All of Most of Some of A little of None of
the tune the tune the tune the tune the tune
▼ ▼ ▼ ▼ ▼
Afromntviied Ie« ‘ham vnn
would life □..... □ »....... □ >.......... ... CL
Did w ork or other xnxines 
less carefullv than ir.ual □..... □ ........ . .O* -....... □... ....Q *
5- Duiing the past 4 weeks, 1m>w much did pain interfere with sour noimal 
work (including both work outside the home and housework)?





6. These questions are about how you feel and bon things have been with you 
during the past 4 weeks. For each question, please give the one answer that 
comes closest to the way you have been feeling. How much of the time 
duiing the past 4 weeks...




Did you have a lot of eaersrv’










▼ ▼ ▼ ▼
.....□.... □ □ •......
O:- ...... □ .....□«
□ .... □ ..... ...... -O'
Duiing the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with 
friends, relatives, etc.)?
.ah of Most of Some of A Uttle of None of
the ume theume thenme the Time die time
▼ ▼ ▼ ▼ ▼
□ □ : □ □ .




Appendix 12 Draft Interview Schedule
Draft interview schedule
Opening statement
Mr/Ms X, today we are going to talk about how your heart trouble affects your daily life and if you 
feel things might be improved.
Questions
Tell me about a typical day
What are the main problems you face at the moment due to your heart trouble?
How do you manage around the house?
Do you get out of the house?
What has helped you cope with your heart trouble?
Have you had any problems getting help in any way?
Who do you currently see with regard to your heart trouble e g. GP/ Hospital Dr. / District Nurse/ 
Heart failure nurse?
Is there anything you would like to see available for people with heart trouble that you currently 
don’t have access to?
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Do you have any needs which you feel aren’t being met at the moment?
What are your thoughts/ feelings on the support you receive?
Is there anything else you would like to talk about?
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Appendix 13 SF-12 Aggregate report
Main study SF Comparison for Total Sample
Demographic Profile Survey Comments
Sample Size 90 SF- !2v2'’' Survey
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